The Cryptonomist

Liquidia stock cratered 57.19% on Wednesday, closing at $30.26 versus $70.69 on 2026-09-29, after a federal court ruled against its YUTREPIA lung drug in a patent dispute with United Therapeutics. Volume surged to 22,770,901 shares, reshaping the technical picture across every timeframe.
LQDA — daily chart with candlesticks, EMA20/EMA50 and volume.
Key takeaways
Liquidia stock plunged 57.19% on Wednesday, closing at $30.26 from a prior close of $70.69, with volume reaching 22,770,901 shares.
The daily RSI14 collapsed to 20.23, deep in oversold territory, while price closed well below the lower Bollinger Band at $49.45.
Price sits beneath all major EMAs across daily, hourly, and 15-minute timeframes, confirming a structural bearish breakdown.
After the close, BTIG cut its rating on Liquidia stock to neutral, tied directly to the patent ruling.
Hourly RSI14 at 18.38 and 15-minute RSI14 at 17.47 signal extreme momentum exhaustion, raising short-term mean-reversion risk.
What Happened: Liquidia Stock and the YUTREPIA Ruling
During Wednesday’s session, a Yahoo Finance report said the US District Court for the District of Delaware found Liquidia’s lung drug infringes a key United Therapeutics patent. It described the ruling as a major blow to the treatment’s commercial outlook. Liquidia CEO Roger Jeffs said the company disagrees with the decision and will “pursue all available appellate options.”
Separately, an Investing.com report published during the session noted that options activity surged after the ruling sank the stock 48%. The spike underlined how abruptly positioning shifted intraday.
After the close, a Seeking Alpha report said Liquidia plunged 57% on the litigation update, broadly in line with the final session change. Also after the close, an Investing.com report said BTIG cut its rating on Liquidia stock to neutral following the patent ruling. Because the rating action came after Wednesday’s close, it is a post-session analyst reaction — not something that shaped the day’s trading.
Daily Trend: Structural Damage Is Severe
Wednesday’s daily candle tells the story. It opened at $70.54, hit a high of $71.93, plunged to a low of $29.86, and closed at $30.26. The 14-day ATR of 6.38 confirms volatility has expanded well beyond typical conditions.
Price now trades beneath all three major daily EMAs. The 50-session EMA at $69.67 sits above the 20-session EMA at $65.88. In turn, that sits above the 200-session EMA at $56.91. That ordering is not a clean bearish stack. However, with price at $30.26 sitting far below all three lines, the stock has detached sharply from its recent trend structure.
Momentum backs this up. The daily RSI14 has collapsed to 20.23, deep into oversold territory. Meanwhile, the MACD line sits at -3.86 against a signal line of -2.15, leaving a negative histogram of -1.71. Price has also closed well below the lower Bollinger Band at $49.45. The midline sits at $66.48 and the upper band at $83.52.
Notably, a close this far outside the lower band is unusual. It points to a capitulation-style move rather than an orderly pullback. On the daily pivot grid, price is wedged between the pivot point at $44.02 and first support at $16.10. Resistance at $58.17 remains well out of reach.
Hourly Timeframe Confirms the Bearish Read
The 1-hour chart reinforces the daily picture. Price at $30.19 sits beneath the 20-hour EMA at $58.00. That sits beneath the 50-hour EMA at $64.05, which in turn sits beneath the 200-hour EMA at $69.87. This is a textbook bearish alignment, with every moving average stacked above price in descending order of recency.
Hourly RSI14 at 18.38 is even more stretched than the daily reading. The MACD line at -8.03 versus a signal of -3.39 produces a histogram of -4.65. That is a wider negative gap than on the daily chart. Therefore, the shorter-term trend confirms the daily bias with greater force.
The hourly pivot point sits at $30.95, with resistance at $32.04 and support at $29.10. Price is currently pinned just under the pivot.
15-Minute Execution Context
On the 15-minute chart, the same bearish ordering holds. Price at $30.19 sits below the 20-period EMA at $47.36. That sits below the 50-period EMA at $58.53, which in turn sits below the 200-period EMA at $65.94.
The 15-minute RSI14 at 17.47 confirms extreme oversold conditions. The MACD histogram of -2.27, with the line at -10.43 and signal at -8.16, shows sellers pressing lower into the close. The 15-minute pivot point stands at $30.41, with resistance at $30.96 and support at $29.64. Price sits just under the pivot, within range of that nearby support.
For short-term positioning, this matters mainly as a map of reaction levels. It is not a trend signal in its own right. At this timeframe, the chart simply confirms that sellers remained in control into the final quarter-hour of the session.
Bullish Scenario: What Would Support a Bounce
Still, a near-term bounce is not out of the question. Oversold readings are stretched across all three timeframes. For that scenario to gain traction, price would first need to reclaim the 15-minute pivot at $30.41. Then it would need to retake the hourly pivot at $30.95. A sustained move above hourly resistance at $32.04 would be the first real sign that immediate selling pressure has eased.
On the news side, any update on appellate options could shift sentiment if the market reads it as improving the company’s odds. However, until price reclaims meaningful daily-chart levels like the pivot at $44.02, any bounce faces a credibility test. It would likely be seen as a relief move within a broken trend — not a reversal.
Bearish Scenario: What Would Confirm Further Downside
On the other hand, the bearish case remains intact as long as price stays capped below the hourly and daily EMAs. A break below hourly support at $29.10 would be the first warning. A subsequent failure to hold the 15-minute support at $29.64 would suggest sellers are not done.
Further out, a slide toward daily first support at $16.10 would confirm a deeper story. Wednesday’s move would mark the start of a deeper repricing, not an isolated shock. The post-close BTIG downgrade to neutral adds a layer of analyst caution. Tied directly to the patent ruling, this would need to reverse before the bullish case could be taken seriously.
Similarly, widening negative MACD histograms on the daily and hourly charts would invalidate any bullish attempt. They would confirm trend continuation to the downside.
Liquidia Stock: Technical Outlook After the 57% Plunge
Overall, Liquidia stock enters the new session with a structurally broken daily chart. The hourly chart confirms the bearish trend with cleanly stacked EMAs. The 15-minute chart is still searching for footing near session lows.
At the same time, RSI readings in the high teens and low twenties across every timeframe carry a clear message. Sharp counter-trend bounces are a real possibility at any point. Elevated options activity noted in Wednesday’s session adds to the sense that positioning remains unsettled.
Given the scale of Wednesday’s move, the pending appellate process, and the fresh analyst rating cut, volatility is likely to stay elevated. Any near-term technical signal should be treated with caution until the litigation picture becomes clearer.
FAQ
What caused Liquidia stock to drop 57% on Wednesday?
A federal court ruling in the YUTREPIA patent dispute found Liquidia’s lung drug infringes a key United Therapeutics patent. The decision dealt a major blow to the treatment’s commercial outlook. The ruling triggered the sharpest single-session decline on record for the stock.
Where does Liquidia stock stand technically after the sell-off?
The stock trades below all major daily, hourly, and 15-minute EMAs. The daily RSI14 collapsed to 20.23, deep in oversold territory, and price closed well below the lower Bollinger Band at $49.45. The MACD histogram on every timeframe remains firmly negative.
What are the key levels to watch for Liquidia stock?
On the downside, hourly support sits at $29.10 and daily first support at $16.10. For a bounce, price needs to reclaim the 15-minute pivot at $30.41 and the hourly pivot at $30.95. A sustained move above hourly resistance at $32.04 would be the first sign of easing selling pressure.
Did any analysts change their rating on Liquidia stock after the ruling?
Yes. After Wednesday’s close, BTIG cut its rating on Liquidia stock to neutral, tying the downgrade directly to the patent ruling. This reflects post-session analyst caution rather than an intraday driver of the sell-off.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

ImmunityBio stock surged 6.91% to close at $9.44 on Wednesday, breaching $10 intraday for the first time since March. That breakout through a level untouched for months now anchors the bullish case building across the daily chart.
IBRX — daily chart with candlesticks, EMA20/EMA50 and volume.
Key takeaways
ImmunityBio stock closed at $9.44 on Wednesday, up 6.91%, after touching $10.09 intraday — the first breach of $10 since March.
The daily chart shows a fully stacked bullish EMA alignment: 20-session at $8.48, 50-session at $8.14, and 200-session at $6.63.
Daily RSI14 at 64.57 signals strong momentum without being overbought, leaving room for further upside.
The close above the upper daily Bollinger Band at $9.25 indicates expanding upside volatility, though a near-term pause is possible.
Reclaiming the daily pivot at $9.48 on a closing basis is key to confirming the breakout and targeting $10.05 resistance.
Daily Structure Turns Decisively Bullish for ImmunityBio Stock
The daily structure now decisively favors buyers. ImmunityBio stock sits above the 20-session EMA at $8.48, which in turn sits above the 50-session EMA at $8.14. The 50-session EMA itself sits above the 200-session EMA at $6.63. This is a fully stacked bullish alignment — the kind of setup that attracts trend-following flow. The daily RSI14 at 64.57 backs this up: strong, but not yet overbought, leaving room for the move to extend.
Momentum Indicators Reinforce the Breakout
Momentum indicators reinforce the bullish read. MACD on the daily chart stands at 0.28 against a signal of 0.21, producing a positive histogram of 0.07. Momentum is positive and has not rolled over. Notably, the close at $9.44 pushed through the upper Bollinger Band at $9.25. A close outside the upper band after a near-7% session signals expanding upside volatility rather than exhaustion. Still, it raises the odds of a near-term pause as the band catches up with price.
The daily ATR14 reads 0.57, and the session’s $1.19 high-low spread confirms volatility has stepped up materially. The daily pivot sits at $9.48, with resistance at $10.05 (R1) and support at $8.86 (S1). Wednesday’s close at $9.44 landed just below that pivot despite the session’s strength. Reclaiming $9.48 on a closing basis would argue for a more decisive push toward the $10.05 resistance.
Multi-Timeframe Analysis of ImmunityBio Stock
The hourly chart confirms the bullish daily read with another fully stacked EMA alignment. Price at $9.43 sits above the 20-hour EMA at $9.17. That sits above the 50-hour EMA at $8.86, which sits above the 200-hour EMA at $8.30. The hourly RSI14 at 59.91 is constructive without being stretched. MACD mirrors the daily reading almost exactly: a line of 0.28, a signal of 0.21, and a positive histogram of 0.07. Momentum has not diverged between the two timeframes.
Meanwhile, the hourly Bollinger setup leaves room to the upside. Price at $9.43 trades comfortably inside the bands, with the midline at $9.05 and the upper band at $10.00. Unlike the daily breakout, this gives the move breathing space before it would need to test resistance again. The hourly pivot sits at $9.50, with R1 at $9.59 and S1 at $9.34. Price hovers around the pivot zone, neither decisively above nor below it.
The 15-Minute Chart Signals Short-Term Digestion
However, the picture complicates on the 15-minute chart. This timeframe exists for execution timing, not trend direction. Here, price at $9.43 sits below the 20-period EMA at $9.61. Yet it remains above the 50-period EMA at $9.35 and the 200-period EMA at $8.82 — a mixed, non-aligned setup. The 15-minute RSI14 at 43.35 sits below the midpoint, and MACD has turned negative with a histogram of -0.07. Price has also slipped below the 15-minute lower Bollinger Band at $9.49.
Taken together, this points to a short-term pullback or consolidation following the sharp intraday advance. It is not a reversal of the broader trend. Therefore, the conflict across timeframes is a timing issue rather than a directional one. Daily and hourly structure both argue for continuation. The 15-minute chart simply reflects the market digesting a large single-day move before deciding its next step.
Fundamental Backdrop for IBRX
Beyond the chart, institutional interest adds a fundamental layer to the ImmunityBio story. A Yahoo Finance report noted that the GA-Courtenay Special Situations Fund favors ImmunityBio. The fund, managed by Green Ash Partners, describes this as a $5.8 billion cancer market opportunity.
Separately, a Yahoo Finance futures roundup published after Wednesday’s close flagged IBRX among stocks in focus. The roundup, which appeared heading into a jobs report, also noted a sharp climb in the 10-year Treasury yield. This provides useful macro context, though it cannot explain Wednesday’s session since it appeared after that close.
Bullish and Bearish Scenarios
The bullish scenario requires reclaiming the $9.48 daily pivot, while the bearish case needs a break below $8.48 to gain traction. Overall, the weight of evidence favors bulls across the daily and hourly timeframes.
For the bullish scenario to extend, ImmunityBio stock would need to reclaim the daily pivot at $9.48 and hold above it. This would open the path toward the $10.05 resistance (R1) and potentially retest the $10.09 intraday high already printed this week. Sustained hourly closes above the $9.50 pivot would support that continuation, provided the daily RSI stays below overbought extremes. A fresh push above the daily upper Bollinger Band on strong follow-through volume would add further conviction.
On the other hand, the bearish case would need a clear break of the daily EMA20 at $8.48. It would also require a loss of the $8.86 support (S1) to gain real traction. A failure to reclaim the daily pivot, combined with the hourly MACD histogram turning negative, would signal the breakout is losing force rather than consolidating. In that scenario, the move back toward $8.86 and the 50-session EMA at $8.14 would become the levels to watch.
Overall, the weight of evidence across the daily and hourly timeframes favors the bullish thesis for ImmunityBio stock. The 15-minute pullback reads as short-term digestion rather than a trend change. At the same time, the breakout above the upper daily Bollinger Band and the elevated ATR14 suggest volatility will stay elevated in either direction. Positioning around current levels requires acknowledging that uncertainty — the stock has just made a notable technical statement. However, what matters most is confirmation — a decisive close above the $9.48 pivot — rather than the move itself.
FAQ
What is the current trend for ImmunityBio stock?
The daily chart shows a fully stacked bullish EMA alignment with price above all three key moving averages. The RSI14 at 64.57 confirms strong momentum without being overbought, leaving room for the move to extend.
What resistance levels should investors watch?
The daily pivot at $9.48 is the immediate level to reclaim on a closing basis. Above that, R1 at $10.05 and the recent intraday high of $10.09 serve as the next key resistance targets for ImmunityBio stock.
Is the 15-minute pullback a cause for concern?
The 15-minute pullback reflects short-term digestion following a sharp advance, not a trend reversal. Daily and hourly timeframes both maintain bullish alignment, making this a timing issue rather than a directional shift.
What would invalidate the bullish thesis?
A clear break below the daily EMA20 at $8.48 and a loss of S1 support at $8.86 would signal the breakout is losing force. In that scenario, a move toward the 50-session EMA at $8.14 would become the level to watch.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

The Banque de France issued new guidance on October 1st, 2026, aimed at clearing up long-running confusion between stablecoins and central bank digital currencies. The Banque de France stablecoin guidance spells out what separates privately issued tokens from state-backed digital money, a distinction the French central bank says matters for protecting monetary sovereignty across the Eurozone.
Key takeaways
The Banque de France published guidance on October 1st, 2026, clarifying the defining characteristics of stablecoins.
The guidance draws a clear line between stablecoins and central bank digital currencies.
Stablecoins are described as privately issued digital tokens pegged to fiat currencies to maintain price stability.
The central bank frames the move as a way to protect European monetary sovereignty.
Financial sector stakeholders are encouraged to take part in the ongoing regulatory conversation.
Banque de France Issues New Guidance on Stablecoins
The core of the Banque de France stablecoin guidance is a working definition that separates two kinds of digital money that often get lumped together in public conversation. According to the Banque de France, the new guidance addresses the complexities surrounding stablecoins directly, giving regulators, banks and the public a clearer reference point for what these tokens actually are and how they differ from money issued by a central bank.
Clarification of Stablecoin Characteristics
Stablecoins, as described in the guidance, are privately issued digital tokens pegged to fiat currencies and designed to maintain price stability. That definition matters because it draws a firm boundary: these are not government-issued money, even though they are built to track the value of currencies like the euro or the dollar. The distinction sounds technical, but it has real consequences for how regulators classify risk, oversight and consumer protection around crypto assets.
Distinction from Central Bank Digital Currencies
The guidance also draws a sharp contrast between stablecoins and central bank digital currencies. Unlike stablecoins, central bank digital currencies are issued directly by a monetary authority, and the Banque de France plays an active role in developing this category of digital money. By spelling out where one ends and the other begins, the central bank is effectively setting the vocabulary that future rulemaking in Europe is likely to use.
Protecting European Monetary Sovereignty
The stated goal behind the new framework is to protect European monetary sovereignty as stablecoins gain ground in everyday financial activity. This matters because stablecoins, often pegged to the US dollar rather than the euro, can quietly shift where monetary influence sits if they become widely used for payments or savings inside the Eurozone. By clarifying definitions now, the Banque de France is laying groundwork that could shape how much room private stablecoin issuers have to operate without encroaching on functions traditionally reserved for central banks.
Alignment with Global Regulatory Trends and Call for Financial Sector Engagement
This move is not happening in isolation. The Banque de France stablecoin guidance lines up with a broader pattern of increasing scrutiny on digital currencies worldwide, as regulators everywhere try to catch up with how fast stablecoins have grown in payments and trading. As stablecoins keep gaining traction, central banks and supervisors are under pressure to offer frameworks that keep financial stability intact without choking off innovation.
The Banque de France is explicitly inviting participation from the industry it oversees. Stakeholders across the financial sector are encouraged to engage with the discussion around stablecoin regulation, a signal that the current guidance is meant to open a dialogue rather than close one.
Potential Impact on Future Regulatory Frameworks and Role in Digital Currency Development
Because the Banque de France carries weight well beyond its own borders, this guidance could influence future regulatory frameworks across Europe. France’s central bank has been an active voice in shaping how central bank digital currencies are built and governed, and its definitions around stablecoins may end up feeding into rules that apply far beyond the French market.
Why this matters for the broader market: clearer definitions tend to reduce ambiguity for issuers, exchanges and institutional players trying to figure out which rulebook applies to which token. At the same time, stablecoin regulation in Europe is still taking shape, and how quickly other authorities adopt similar language remains an open question. Traders and stakeholders watching this space will likely track whether other European regulators pick up the same framing, and whether it leads to concrete rules affecting how stablecoin issuers operate day to day.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

Crypto hacks caused over $766 million in losses during September 2026, making it the worst month of the year for digital asset theft so far. Two separate blockchain security firms tracked the damage, and while their incident counts differed, both arrived at remarkably close loss estimates — a sign of just how large and unmistakable the month’s breaches were.
Key takeaways
September 2026 marked the costliest month this year for crypto hacks and exploits, with losses exceeding $766 million.
According to PeckShield, there were 55 significant incidents totaling $766.5 million, whereas CertiK documented 97 incidents amounting to $768.4 million.
Most of September’s losses stemmed from two events: the $388 million Bitget hack and the $320 million Liquid Network exploit.
Reports indicate that over $270 million taken in the Liquid Network exploit was eventually recovered.
According to CertiK’s 2026 dashboard, there have been 656 security incidents this year so far, resulting in $2.68 billion in total losses.
September 2026 Marks Worst Month for Crypto Hacks
September’s total marks a sharp jump from August, according to both firms tracking the sector. PeckShield counted 55 major incidents during the month and put the stolen total at $766.5 million. CertiK, meanwhile, recorded a higher number of incidents — 97 in all — and estimated the month’s losses at $768.4 million.
The two figures land less than $2 million apart, which is notable given that the firms use different counting methods and track different sets of incidents. That overlap lends weight to the scale of September’s losses: this wasn’t a single catastrophic breach skewing the numbers, but a month packed with activity across the crypto ecosystem.
Why this matters: when two independent trackers converge on nearly identical totals, it signals that the month’s crypto security incidents weren’t isolated anomalies but part of a broader pattern hitting multiple platforms at once. CertiK summed up the shift bluntly, saying in a statement published Wednesday that “September was a stark reminder of how quickly the threat landscape can shift.”
Bitget and Liquid Network Lead the Month’s Losses
Two attacks dwarfed everything else that happened in September. The Bitget hack accounted for $388 million in losses, while a separate exploit on the Liquid Network resulted in $320 million stolen. Combined, those two incidents made up roughly $708 million — the overwhelming majority of the month’s total.
North Korea suspected in Bitget breach
According to CEO Gracy Chen, Bitget identified 19 unauthorized transfers originating from portions of its hot and warm wallet systems during the afternoon of September 24, with cold wallets remaining unaffected. Per CNBC, Chen noted that investigators traced internet protocol addresses to VPN services previously associated with a North Korean hacking group, and that the attack’s characteristics matched patterns from prior operations linked to that nation.
According to Chen, Bitget’s security team found that an attacker had compromised a vital backend wallet system, exploited it to falsify transfer data, and activated the exchange’s authorization-signing process, though a private key breach was ruled out. According to Bitget, the full amount lost will be covered by its User Protection Fund, which contains more than $464 million.
Liquid Network’s partial recovery
The Liquid Network exploit came in just behind Bitget’s in size, with $320 million taken. In contrast to the Bitget incident, however, a substantial share of the funds taken in the Liquid Network exploit — over $270 million — was later returned, according to reports cited by Cointelegraph. Both incidents rank among the largest crypto thefts recorded so far this year, and the partial recovery on Liquid Network stands out as one of the rare bright spots in an otherwise costly month.
Smaller Incidents and the Bigger 2026 Picture
Not every September breach made headlines on the scale of Bitget or Liquid Network, but several smaller platforms still took real hits. Safe Wallet lost $7.8 million, DCENT lost $6 million, and Duelbits lost $5.9 million. Combined, those three incidents added $19.7 million to the month’s total — a relatively small slice next to the two headline attacks, but still a reminder that smaller crypto platforms remain exposed.
Zooming out to the full year puts September’s damage into sharper context. CertiK’s security dashboard shows 656 security incidents across 2026 so far, with cumulative losses of $2.68 billion. September’s losses alone represent more than 25% of that entire yearly total, even though the month’s 97 incidents make up only about 15% of all incidents CertiK has recorded this year.
That gap between incident share and loss share matters. It means September wasn’t simply a busy month for hackers — it was a month where a relatively small number of attacks did outsized financial damage, driven almost entirely by the Bitget and Liquid Network breaches.
A Shifting Threat Landscape
CertiK’s own framing of the month captures the broader concern for the industry. Beyond the statement about how fast the threat landscape can shift, the firm’s data shows September pushing the 2026 running total to $2.68 billion in losses — a figure that keeps climbing as the year progresses.
For exchanges and wallet providers, the September numbers underline a persistent problem: backend wallet systems and third-party integrations remain prime targets, and attackers tied to sophisticated operations — as suspected in Bitget’s case — continue to probe infrastructure that platforms assume is secure. For users and investors, the month serves as a reminder that even well-funded platforms with dedicated protection funds aren’t immune, though Bitget’s case shows that insurance-style reserves can at least limit the fallout for customers when a breach does happen.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

SBI Holdings has officially absorbed one of Japan’s most prominent cryptocurrency exchanges, closing a deal that reshapes the competitive map for digital asset trading in the country. The SBI acquisition Bitbank transaction was completed on October 1, turning Bitbank, operator of the crypto exchange platform “bitbank,” into a wholly owned subsidiary of the financial conglomerate. The deal, worth ¥46.7 billion (roughly $294.9 million), closes a chapter that began with a June announcement and wraps up almost exactly on the timeline SBI originally projected.
Key takeaways
SBI Holdings completed its full acquisition of Bitbank on October 1 for ¥46.7 billion (about $294.9 million).
Bitbank is now a 100% subsidiary of SBI Holdings, following a deal first announced on June 25.
The transaction combined share purchases from existing shareholders with a subscription to a third-party allotment of new shares.
Tomohiko Kondo, president of SBI VC Trade, joined Bitbank’s board, while Bitbank CEO Noriyuki Hirosue is set to become an outside director at SBI VC Trade.
Bitbank says its existing exchange services will continue unchanged for current users.
SBI Holdings Finalizes Acquisition of Bitbank for ¥46.7 Billion
The deal brings one of Japan’s largest retail-focused crypto exchanges fully under SBI’s corporate umbrella, marking a clear strategic bet on the country’s expanding digital asset market. SBI Holdings confirmed the completion of the acquisition on October 1, roughly three months after first revealing its intentions.
Acquisition Announcement and Timeline
On June 25, SBI Holdings disclosed that it had finalized a basic agreement together with a share transfer agreement designed to turn Bitbank into a fully owned subsidiary. From the outset, the company projected a completion date around October, and the SBI Holdings crypto expansion plan landed almost exactly on that schedule. That kind of precision matters in M&A circles, where crypto-related deals have sometimes dragged out over regulatory or valuation disputes.
Transaction Structure and Share Transfers
The ¥46.7 billion price tag didn’t come from a single transaction. Instead, SBI structured the deal in three distinct steps. First, SBICAH LLC, a wholly owned subsidiary of SBI, purchased shares from existing Bitbank shareholders, including Noriyuki Hirosue. Second, SBICAH subscribed to a third-party allotment of newly issued Bitbank shares. Third, Bitbank itself repurchased shares held by MIXI and Ceres, converting them into treasury stock. Together, these moves consolidated full ownership of Bitbank under SBI Holdings.
Management Restructuring Following Acquisition
Ownership changes typically bring boardroom changes too, and this deal is no exception. SBI has woven leadership from both companies together rather than simply replacing Bitbank’s existing management.
New Board Appointments and Cross-Company Governance
Bitbank’s board of directors now includes Tomohiko Kondo, who serves as president of SBI VC Trade. Mirroring that appointment, SBI VC Trade is set to welcome Bitbank CEO Noriyuki Hirosue as one of its outside directors. This cross-appointment arrangement effectively links the governance of SBI’s existing crypto arm with its newly acquired exchange, a structure that signals an intent toward coordination rather than a clean separation between the two businesses.
Bitbank’s Exchange Services and Strategic Impact
What matters most to ordinary users is whether the platform experience itself will shift, and for now nothing is changing. Bitbank has indicated that it will keep running its current exchange services unaltered following its entry into the SBI Group, so existing users should notice no difference from the setup they’re already familiar with.
Continuity of Exchange Services Post-Acquisition
Keeping Bitbank’s operations intact likely matters for retention. Bitbank has built its reputation as one of Japan’s leading exchanges by trading volume, with a customer base centered heavily on retail investors — a different crowd than the institutional clients SBI VC Trade has historically served.
Expansion of SBI Group’s Retail-Focused Crypto Business
That difference is precisely the point. SBI VC Trade has expanded its operations primarily around institutional investors and tight integration with the group’s broader financial services, while Bitbank brings deep Bitbank retail investors relationships to the table. Opting for full integration instead of a partnership or minority stake lets SBI Group instantly expand its consumer-oriented exchange operations at scale, bypassing the years it would otherwise take to grow that user base organically.
Context of the Acquisition in Japan’s Growing Crypto Market
This deal doesn’t exist in isolation — it reflects a broader pattern of established financial institutions moving deeper into digital assets. Involvement by major financial groups in Japan’s crypto asset exchange sector has been intensifying, driven by the expansion of the crypto market since 2024 and the clarification of domestic regulations.
Market Expansion and Regulatory Clarity Since 2024
Clearer rules tend to lower the perceived risk for large, regulated financial players entering a market that was once seen as speculative or legally murky. That shift has encouraged established institutions to treat Japan crypto exchange operations as a legitimate growth area rather than a side experiment, and SBI’s full acquisition of Bitbank can be read as one of the deals symbolizing that change.
Increasing Involvement of Major Financial Groups
SBI Group, under Chairman and President Yoshitaka Kitao, has pursued a strategy fusing finance and technology for years, and its crypto footprint already includes mining operations and token issuance support. Strengthening its exchange business through Bitbank appears aimed at broadening customer touchpoints across both retail and institutional segments. Whether rivals respond with similar consolidation moves of their own may become the next storyline to watch in Japan’s crypto exchange sector.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

Citi has lifted its 12-month price target for Bitcoin to $113,000 from $82,000, a revision dated October 1 that marks one of the bank’s more notable upward adjustments to its crypto outlook this year. The updated Citi Bitcoin forecast reflects stronger crypto market activity, a friendlier macro backdrop, and the expectation that institutional money will keep trickling back into digital assets, though not in one sudden wave.
Key takeaways
On October 1, Citi lifted its 12-month Bitcoin price target from $82,000 to $113,000, marking a rise of about 37.8%.
The bank expects $5 billion of crypto inflows over the next 12 months, arriving gradually rather than all at once.
Citi also raised its Ether target to $3,028 from $2,240.
Although the digital-asset sector took a hit when the Senate failed to move the Clarity Act forward, announcements of SEC rules helped ease the negative impact on sentiment.
Over the three months ending October 1, Bitcoin gained nearly 40%, bringing its year-to-date decline down to roughly 4%.
Citi Raises Bitcoin and Ether Price Forecasts
The new Citi Bitcoin forecast represents a $31,000 jump from the bank’s previous call, and it changes how Citi frames Bitcoin’s potential over the coming year. Rather than pointing to an imminent rally, the bank is betting on a slower rebuild of institutional demand that eventually pushes the price higher.
Bitcoin Target Increased by 37.8%
The move from $82,000 to $113,000 works out to roughly a 37.8% increase, a substantial upgrade by Wall Street standards. It signals that Citi now sees meaningfully more room for Bitcoin to climb over the next year than it did before this revision, driven by a mix of stronger crypto activity and a more supportive macro environment.
Ether Forecast Also Upgraded
Citi didn’t stop at Bitcoin. The bank also raised its 12-month target for Ether to $3,028 from $2,240. Still, Bitcoin remains the center of attention in this revised outlook, since Citi explicitly ties its bullish case to the return of institutional inflows and a gradual increase in allocations from advisers and brokerages.
Gradual Institutional Inflows as Key to Outlook
At the heart of Citi’s thesis is a bet on patience rather than a sudden flood of capital. The bank anticipates $5 billion of crypto inflows over the next 12 months, but frames that figure as the product of a slow, steady rebuild rather than a single burst of buying.
Expectation of $5 Billion Crypto Inflows Over 12 Months
That $5 billion inflow estimate is the clearest numerical anchor behind the new target. It implies Citi’s base case assumes institutional participation returns incrementally over the coming year, rather than in one aggressive wave tied to a specific catalyst.
Measured Pace of Allocations Emphasized
Citi expects advisers and brokerages to raise their Bitcoin allocations gradually, not all at once. This matters because a slow accumulation of demand behaves differently than a concentrated surge. If flows build steadily, they could provide a persistent, ongoing bid for Bitcoin. But if that demand stalls or reverses, the revised $113,000 target loses much of its near-term support. The forecast also depends on sustained demand and continued ETF inflows, not just a short-term price pop, which is why Citi frames this as a gradual-allocation scenario rather than a guaranteed trajectory.
Regulatory Setbacks and Macro Factors Influence Forecast
Regulation and macro conditions both played into Citi’s revised thinking, pulling in somewhat different directions. One development weighed on sentiment, while others appear to have helped offset the damage.
US Senate’s Clarity Act Failure Weighs on Industry
When the Senate failed to advance the Clarity Act, it dealt a blow to the broader digital-asset industry. Legislative uncertainty of this kind tends to cloud the regulatory picture that institutional investors rely on before committing larger allocations to crypto.
SEC Announcements Helped Damp Negative Sentiment
Despite that legislative stumble, Citi said subsequent rule announcements from the Securities and Exchange Commission helped dampen the negative sentiment that followed. In other words, the regulatory setback wasn’t allowed to fully define the mood around digital assets heading into this forecast revision.
Supportive Macro Backdrop Aids Bitcoin Momentum
Bitcoin’s recovery from its July lows also coincided with a softer US dollar and the Treasury’s move to buy back longer-dated bonds, according to Reuters. Those macro factors can shape broader risk appetite and financial conditions, though the timing alone doesn’t prove either development directly caused Bitcoin’s advance. The relationship between Treasury yields, Federal Reserve expectations, and Bitcoin’s outlook remains relevant simply because that macro support can shift as rates and the dollar move in the months ahead.
Market Positioning and Forecast Caveats
Context matters here. Citi’s revised target comes after a real, measurable rebound in Bitcoin’s price, but the bank is careful to frame the new number as a reference point rather than a prediction investors should trade on directly.
Recent Bitcoin Rally Narrowed Yearly Losses
In the three months leading up to October 1, Bitcoin surged almost 40%, cutting its year-to-date loss to about 4%. That recovery improves the broader momentum picture heading into the new forecast, though a rally already recorded doesn’t guarantee the next leg higher follows the same path.
Forecast Serves as Reference, Not Trading Signal
Citi frames the $113,000 figure as a higher 12-month reference point, not a standalone buy signal. This forecast gains credibility if ETF demand recovers and grows according to the bank’s gradual-allocation scenario, provided crypto activity and macroeconomic conditions remain favorable. The relevant signal, as Citi frames it, is sustained demand over time, not a single session of positive flows. A renewed stretch of outflows would directly challenge the demand assumption behind this upgrade.
Taken together, the revised Citi Bitcoin forecast captures a market that has already clawed back much of its annual losses, but whose next move depends less on momentum and more on whether institutional allocators keep showing up, quarter after quarter, rather than just once.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

European regulators have opened a formal line of inquiry into how Binance has kept serving customers across the bloc without holding a license under the Markets in Crypto-Assets regulation, known as MiCA. The Binance EU MiCA investigation centers on the exchange’s use of a legal carve-out called “reverse solicitation,” which in theory lets overseas firms deal with EU clients only when those clients approach the company first, with no advertising or active promotion involved. EU regulators are now examining whether Binance stretched that exemption well beyond its intended scope after missing the deadline to get properly licensed.
Key takeaways
EU regulators, led by ESMA, are investigating whether Binance improperly used the reverse solicitation exemption to keep serving customers after failing to secure a MiCA license.
Binance withdrew its MiCA license application in Greece in June following political intervention and central bank opposition.
ESMA says reverse solicitation “must be interpreted very narrowly” and is not a workaround for MiCA licensing requirements.
Binance stopped crypto trading in France but kept opening new EU accounts in other markets after the licensing deadline passed.
Binance faces a separate US Department of Justice probe into possible Iran sanctions violations, adding to its regulatory pressure.
EU Regulators Scrutinize Binance’s Use of the Reverse Solicitation Exemption
At the heart of the matter is a narrow legal provision that was never meant to become a backdoor into the European market. Regulators want to know whether Binance’s EU customer relationships genuinely started on the customers’ own initiative, or whether the exchange’s marketing and continued account openings crossed a line MiCA was designed to prevent.
How Reverse Solicitation Is Supposed to Work
Under Article 61 of MiCA, an overseas crypto firm can legally serve an EU client without local authorization only if that client initiates contact entirely on their own, without any prior advertising, promotion, or solicitation from the company. A firm cannot claim the exemption if it, or anyone acting for it, had previously reached out to prospective customers in the EU through marketing or other communications. Even contractual language asserting that a client approached the company independently does not change the facts of how the relationship actually began.
ESMA’s Position on the Exemption
ESMA has been blunt about how it reads the rule. The regulator stated that the exemption “must be interpreted very narrowly” and must be treated as “the exception and not be used to circumvent MiCA requirements.” Some national regulators have already requested detailed information from Binance about its reliance on the exemption, and enforcement action, including fines, is on the table if the exchange’s answers fall short.
A Licensing Journey That Fell Apart in Greece
Binance’s path to full MiCA authorization hit a wall months before this scrutiny began. The exchange failed to secure a MiCA license before the transition period, leaving it without the regulatory standing needed to keep operating freely across the bloc once the grace period expired.
Political Opposition and the Withdrawal
Binance had initially pursued authorization through Greece, a route that would have let it passport a single license across other EU member states. That plan collapsed in June, when the exchange withdrew its Greek application following high-level political intervention and opposition from the central bank. Binance then pivoted toward operating via the UAE instead. The company stated that it “complies with applicable regulatory requirements in the jurisdictions in which it operates” and that its “products and services continue to be reviewed and aligned with relevant regulatory obligations.” Binance added that it is “actively working toward becoming MiCA-authorised” and views the process as “an important step in providing users with a consistent, regulated, and trusted service across the European market.”
France and the Current Patchwork of Access
The clearest sign of how the licensing gap has played out on the ground is France. Binance stopped offering crypto trading services there after failing to obtain a MiCA license, limiting French users to withdrawing their existing crypto holdings rather than trading. Access elsewhere in the EU has been far less consistent, which is precisely what drew regulators’ attention in the first place.
Workarounds Keep Binance Active Despite the Deadline
People with knowledge of the situation say that even though Binance missed the licensing deadline and withdrew its Greek application, the exchange has kept running substantial operations within the EU by relying on various side doors and workarounds. According to ESMA, Binance kept letting users open new accounts in certain European markets even after it pulled its application via Greece back in June.
Users who approached the platform independently were onboarded under the company’s own interpretation of reverse solicitation.
This is where the Binance EU MiCA investigation matters most for the wider market: if a company of Binance’s size can keep significant operations running without full authorization, it raises hard questions about how enforceable MiCA’s licensing regime really is during its early rollout.
Why This Case Could Reshape MiCA Enforcement
ESMA is moving from a setup phase into active enforcement of MiCA, and the agency has flagged reverse solicitation as one of its 2027 supervisory priorities, alongside outsourcing arrangements, operational resilience, liquidity management, and whether firms maintain adequate infrastructure inside the EU. The outcome of the Binance case is widely expected to serve as the first major test of how strictly the exemption will actually be applied. A narrower reading, if regulators push it through, would carry consequences well beyond one exchange, since other overseas crypto firms leaning on reverse solicitation to reach EU customers without full authorization would face the same tightened standard.
The pressure on Binance is not confined to Europe, either. The exchange is also facing a US Department of Justice investigation into possible Iran sanctions violations, led by the Attorney’s Office for the Southern District of New York together with the DOJ’s Criminal Division. Taken together, the parallel EU and US scrutiny signals that Binance’s regulatory footprint is being tested on multiple fronts at once, even as the company insists it is working toward full MiCA authorization.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

Visa and Mastercard already process nearly half of every euro spent on cards across the eurozone, a dominance that has pushed European officials to build a public alternative: a new European Central Bank digital currency known as the digital euro. “Payment systems are not neutral; they are instruments of power,” Gilles Boyer, a French member of the European Parliament, said in June, the same day the European Parliament’s economic affairs committee voted 43 to 14 to back the project. “We Europeans have had many wake-up calls about our dependence on the U.S. We are fully awake now.”
Key takeaways
Visa and Mastercard processed 47% of the eurozone’s card payment value in 2025, according to GlobalData.
A 12-month pilot of the digital euro is set to start in the second half of 2027, with 36 finance firms including Deutsche Bank, Revolut, Adyen and UniCredit taking part.
Businesses across the euro area will be required to accept the digital euro, both in-store and online, by 2029.
The European Central Bank estimates its own development costs at €1.3 billion, while banks could collectively face €4 billion to €6 billion in costs over four years to run the system.
Total noncash payments in the euro area reached €233.8 trillion in 2025, underscoring the scale of the market the digital euro is entering.
The Digital Euro Initiative as a Strategic Move
What Exactly Is the Digital Euro?
Introduced by the European Central Bank, the digital euro is a new digital central bank currency intended to act as an electronic counterpart to the cash the bank already issues. Unlike private payment apps, it would offer people and businesses in the euro area a free, universally accepted way to pay, backed directly by the central bank rather than a commercial network.
That distinction matters. Physical cash is the one form of money the ECB still fully controls, and it is fading fast. According to the ECB, which has already discontinued €500 notes, the proportion of eurozone businesses no longer accepting cash has tripled to 12% over the last three years. As cash use shrinks, officials argue that a European Central Bank digital currency is the only way to keep a public, non-commercial option alive in daily payments.
Reducing Dependence on US Payment Systems
The push behind the digital euro is less about innovation than about leverage. Visa and Mastercard processed 47% of eurozone card payment value in 2025, GlobalData figures show, and the concentration is even starker in the U.K., where 95% of card transactions run through systems owned by the same two U.S. companies. Fifteen of the euro area’s 21 countries still have no domestic digital payment solution of their own, the ECB says, and no single European scheme works seamlessly across the whole bloc.
European policymakers worry about what would happen if access to either U.S. network were ever disrupted, a concern that has sharpened as the Trump administration has leaned more heavily on financial sanctions as a foreign-policy tool. “It won’t be easy to replace any of the existing payment methods overnight if one of the big networks decides to shut down in Europe,” says Radi El Haj, chief executive of RS2, a payments technology firm involved in the pilot. “The ECB wants Europe to have its own foothold rather than depend entirely on foreign-built infrastructure.”
This is where the strategic logic becomes clear: a public digital euro would give the bloc a fallback that doesn’t rely on eurozone payment systems owned abroad. Pierre-Antoine Vacheron, CEO of French payment company Worldline, frames the ambition modestly. “A successful digital euro could boost the international role of the euro, helping Europe remain competitive as global payment systems become increasingly digital,” he says. “It’s not a revolutionary improvement, it’s a genuine gap-filler.”
Pilot Program and Adoption Timeline
The project is moving from policy debate into live testing, with a defined calendar that stretches into the next decade.
36 Finance Firms Join the Digital Euro Pilot
Set to begin in the second half of 2027, a 12-month pilot already has 36 finance firms — including Deutsche Bank, Revolut, Adyen and UniCredit — signed up to participate. Any eventual launch still depends on EU legislation and a later ECB decision to issue the currency.
Mandatory Acceptance by 2029
By 2029, businesses will be required to accept digital euros both in physical stores and online. This requirement grants the project two structural advantages seldom available to private rivals: mandatory acceptance by merchants and mandatory distribution through banks. Once the digital euro launches, retailers throughout the EU will be expected to accept it, while every bank will be required to provide it to its customers. Still, Vacheron cautions that compliance isn’t the same as success: “The real test will be whether it achieves broad everyday adoption.”
Economic and Operational Implications
Development and Bank Costs
Building and operating a parallel payment network across the euro area carries a substantial price tag. The ECB’s projected development costs for the digital euro scheme amount to €1.3 billion ($1.5 billion), with ongoing operating costs expected to run about €300 million ($350 million) per year. Banks face an even heavier load: the ECB estimates the digital euro could collectively cost them €4 billion to €6 billion ($4.7 billion to $7 billion) over four years, in addition to maintaining their current infrastructure. Some of that cost may be recovered by charging merchants a bank-set digital-euro transaction fee — a move critics say would simply recreate the interchange-fee model the project was meant to disrupt, leaving banks to foot a bill for infrastructure nobody ends up using.
Those figures sit against an enormous backdrop: total noncash payments in the euro area reached €233.8 trillion in 2025, a scale that explains both why Brussels sees the current dependence on Visa and Mastercard as risky and why the cost of building an alternative is so large.
For businesses, the calculation looks different. By allowing merchants to skip interchange fees altogether and settle transactions instantly, a digital euro—according to financial services regulatory lawyer Martin Dowdall of Winston Taylor—could help make Europe “a cheaper, more attractive place” to do business. This argument resonates particularly well since, in May 2025, trade groups representing Amazon, Carrefour, H&M, Ikea and other major retailers sent a letter to the European Commission pressing it to rein in what they described as excessive card-scheme fees charged by Visa and Mastercard, noting that such fees had climbed 33.9% between 2018 and 2022.
A standardized payment rail could also simplify Europe’s fragmented checkout landscape, where iDEAL in the Netherlands, Bizum in Spain and Blik in Poland each creates a different experience market by market. “Managing a wide mix of regional payment methods across different markets brings real complexity for businesses,” says Carlo Bravin, head of payments partnerships EMEA at Adyen, though he notes “it’s still too early to see strong merchant demand for the digital euro specifically.” Rebecca Christie, a senior fellow at Bruegel, expects limited immediate impact outside cash-heavy, slower-digitizing economies. “Merchants will want to know, and reduce where possible, the costs of processing the new system before they embrace it,” she says.
Challenges and Competition in Europe’s Payments Landscape
Even as legal mandates support it, the digital euro is entering a market already being shaped by rivals: BNP Paribas, Commerzbank and Rabobank have each thrown their weight behind Wero, a bank-funded digital wallet that already has 50 million users. “By the time a digital euro is issued, Wero could already be established as a significant European omnichannel payment scheme,” says Jacob Rider, senior program director at Projective Group. “That raises difficult questions about whether Europe is effectively developing two solutions to the same strategic problem.”
Christie doesn’t see the two efforts as being in conflict. “It’s important to have a clear public anchor,” she says. “No one wants a situation where the private sector develops something that assumes the role of a public service and then becomes unavailable.” The ECB echoes that framing: “It’s about enhancing people’s freedom of choice,” says Josephine Nachtsheim, the bank’s digital-euro spokesperson, adding that the project is meant to preserve access to central bank money and strengthen “the resilience and strategic autonomy of European payments.”
History offers a sobering check on expectations. Comparable digital-currency trials elsewhere have faced difficulties: the Eastern Caribbean’s DCash pilot was halted in 2024, while Nigeria’s eNaira, which launched in 2021, continues to run but has seen only modest uptake. Dowdall is more direct, calling similar overseas initiatives “complete and utter flops,” while Apostolos Thomadakis, a senior research fellow at the Centre for European Policy Studies, questions whether the public case for the project has even been clearly articulated. “It’s difficult to understand the need for a digital euro,” he says, arguing that official messaging leans too heavily on abstractions like “financial stability, strategic autonomy, or a monetary anchor” that mean little to ordinary people.
Integration adds its own friction. Businesses will need new tools for refunds, reconciliation and outage protection, and El Haj warns the system will demand constant upkeep: “Card networks already push updates twice a year, and the digital euro will likely demand the same ongoing adjustment.” Banks, meanwhile, face the added risk of customers shifting deposits into digital-euro wallets instead of interest-bearing accounts — a second cost layered on top of running a parallel payment system.
A timing issue also lies at the heart of its relevance to global competition, since the digital euro has needed six years to reach the pilot phase. During that period, Washington abandoned its own digital-dollar ambitions, opting instead to pass the GENIUS Act in support of private, dollar-backed stablecoins, which processed about $33 trillion worth of transactions in 2025. “As a direct challenger to U.S. payment dominance, the digital euro is undoubtedly arriving late,” Rider says. “It will launch into a market where consumer payment habits are already deeply established and private European alternatives are scaling.” He adds a sharper warning about what comes next: “Today, European dependence on U.S. card networks is a central concern, but by 2029, the main issue will be the influence of dollar-denominated private digital money.” In that light, the digital euro risks arriving just in time to fight the last war over Europe’s payment infrastructure, even as a new one — fought in stablecoins rather than card networks — is already underway.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

As of October 1, 2026, NEAR trades around $5.46 against USDT, making this Near crypto asset a standout mover while the broader market cools. Total crypto market cap slipped 1.83% over 24 hours to roughly $2.89 trillion, yet NEAR pushes higher on its own momentum.
NEAR/USDT — daily chart with candlesticks, EMA20/EMA50 and volume.
Key takeaways
NEAR trades at $5.46 with the daily RSI at 76.9, firmly in overbought territory.
The EMA20, EMA50, and EMA200 remain stacked bullishly, confirming a sustained uptrend.
Total crypto market capitalization fell 1.83% to roughly $2.89 trillion over 24 hours.
The Fear & Greed Index stands at 74 (“Greed”), signaling elevated risk appetite.
NEAR ecosystem protocols posted fee growth ranging from 40% to over 749% in the past 30 days.
Daily Chart: Strong Trend, Stretched Momentum
On the daily timeframe, NEAR’s regime is unambiguously bullish. Price at $5.46 sits well above the EMA20 at 4.2244, EMA50 at 3.2216, and EMA200 at 2.2036. The clean separation between those three averages reflects a sustained, well-respected uptrend rather than a choppy range.
The daily RSI at 76.9, however, is where the caution flag goes up. That is firmly in overbought territory, and historically readings this hot do not resolve cleanly. They either trigger a sharp mean-reversion flush or a sideways grind that lets momentum cool off without price giving back much ground. The daily MACD still supports the bulls: the MACD line at 0.78016 sits above the signal line at 0.69605 with a positive histogram at 0.084106. Upside momentum is technically still expanding, even as the RSI suggests exhaustion.
Meanwhile, Bollinger Bands on the daily add useful context. With the mid-band at 4.0133 and the upper band at 6.1835, price at $5.46 runs in the upper half of the envelope but has not yet tagged the top. The daily ATR of 0.62564 confirms that swings exceeding half a dollar per day are now normal. Stop placement and position sizing need to respect that range.
Pivot levels frame the next decision zone: the daily pivot point sits at 5.3913, with resistance R1 at 5.6087 and support S1 at 5.2427. Price hovers just above the pivot, keeping the bias constructive as long as that level holds as a floor.
1H and 15m: Momentum Is Cooling, Not Breaking
The hourly chart confirms the bullish macro bias but with noticeably less thrust. EMA20 at 5.3144, EMA50 at 5.1798, and EMA200 at 4.8633 remain stacked bullishly. The RSI at 63.21 is healthy without being overheated — a meaningful contrast to the daily reading of 76.9. That gap is the central tension in this setup: the bigger trend is overbought, yet shorter-term momentum has already cooled.
The hourly MACD backs up that cooling-off story. The MACD line at 0.088393 and signal line at 0.085322 are nearly touching, and the histogram has shrunk to just 0.003071. Momentum is decelerating on this timeframe even though price has not broken down. Bollinger Bands on the 1H, with the mid-band at 5.3457 and upper at 5.4775, show price pressing against the top — short-term buyers remain active but have limited room without a band expansion.
On the 15-minute chart, used strictly for execution timing, the picture stays constructive. EMA20 at 5.4121 sits above EMA50 at 5.3551, which sits above EMA200 at 5.1788, with RSI at 61.86 and a small positive MACD histogram at 0.0082944. The 15m pivot at 5.4667, with resistance at 5.4823 and support at 5.4473, defines a tight range — useful for entries but not for building a directional thesis.
What’s Driving the Tape Beneath the Chart
Moreover, activity data around the NEAR ecosystem provides context for the capital rotation into this asset. NEAR Intents, a bridge protocol, posted a 40.05% increase in fees over 30 days despite daily and weekly pullbacks. THORSwap, a DEX aggregator touching NEAR flows, saw fees jump 477.43% over 30 days and 112.74% over 7 days. DeltaTrade’s fee growth reached 749.45% over the month. The 30-day trend across these venues points to genuine usage growth rather than pure speculation.
Bullish Scenario
If NEAR holds above the daily pivot at 5.3913 and defends S1 support at 5.2427, the uptrend stays intact and the overbought RSI becomes a pause, not a reversal. A move through daily R1 at 5.6087 would open the door toward the upper Bollinger Band near 6.1835. Continued fee growth across NEAR Intents and the DEX ecosystem would give that move fundamental backing. Confirmation would come from the hourly MACD histogram turning higher and RSI reclaiming the 70s without the daily chart breaking its EMA20.
Bearish Scenario
In contrast, the bearish case starts with that daily RSI at 76.9. If NEAR fails to hold the 5.39 pivot zone and slips through S1 at 5.2427, the stretched momentum could unwind quickly given an ATR of 0.62564 per day. A break below the hourly EMA50 at 5.1798 would signal short-term buyers stepping back. A decisive move under the daily EMA20 at 4.2244 would invalidate the bullish structure entirely. With broader market cap already down 1.83%, a Bitcoin slowdown could easily trigger that unwind.
Positioning and Risk
Near crypto now sits at a genuine fork: the daily trend is as bullish as it has been in months, yet the daily RSI is overbought enough that chasing strength without a plan is a mistake. The hourly and 15-minute timeframes behave normally, but that can change fast. With market-wide sentiment at Greed (74) and total market cap already pulling back, conditions favor sharp, two-sided moves. Anyone sizing positions should treat the ATR-driven ranges — roughly $0.62 daily and $0.12 hourly — as the realistic cost of being wrong.
FAQ
What does the overbought RSI reading mean for NEAR?
The daily RSI at 76.9 signals NEAR is in overbought territory. Historically, such readings lead either to a sharp mean-reversion flush or a sideways consolidation that cools momentum without significant price loss. The hourly RSI at 63.21 suggests short-term momentum has already begun cooling, creating a tension between timeframes.
What are NEAR’s key support and resistance levels?
The daily pivot sits at 5.3913, with support S1 at 5.2427 and resistance R1 at 5.6087. A break above R1 opens the path toward the upper Bollinger Band near 6.1835, while losing S1 could trigger a swift unwind toward the hourly EMA50 at 5.1798 and potentially the daily EMA20 at 4.2244.
Is NEAR’s rally backed by actual usage growth?
Yes. NEAR Intents posted a 40.05% increase in fees over 30 days, THORSwap fees jumped 477.43%, and DeltaTrade’s fee growth reached 749.45% over the same period. These trends indicate genuine ecosystem activity rather than pure speculation, offering a more durable foundation for the trend.
What could trigger a bearish reversal for NEAR?
A failure to hold the 5.39 pivot zone followed by a break below S1 at 5.2427 could unwind the overbought daily momentum quickly given the ATR of 0.62564. A move below the hourly EMA50 at 5.1798 would confirm buyers are stepping back, and losing the daily EMA20 at 4.2244 would invalidate the bullish structure entirely.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

The crypto market is rarely subtle about extremes, and the Quant QNT crypto rally is no exception. As of October 1, 2026, QNT trades near $294 on Binance, with daily RSI at 81.43 — a level that typically precedes either a blow-off top or a sharp correction.
QNT/USDT — daily chart with candlesticks, EMA20/EMA50 and volume.
Key takeaways
QNT/USDT trades near $294.12 on the daily chart, well above its EMA20, EMA50, and EMA200.
Daily RSI14 sits at 81.43, deep in overbought territory, while the hourly RSI has cooled to 55.
Price is pressed against the upper daily Bollinger Band at $302.12, signaling an extreme standard-deviation move.
The hourly MACD shows a bearish crossover, hinting at momentum divergence across timeframes.
Total crypto market cap stands at $2.89 trillion with Bitcoin dominance at 58.3% and a Fear & Greed Index of 74.
Daily Timeframe: A Trend Stretched to Its Limits
The daily chart shows QNT in a structurally bullish but clearly overextended position, with price trading nearly double its 20-day moving average. QNT closed at $294.12, sitting far above its EMA20 at $155.61, EMA50 at $106.71, and EMA200 at $79.04. When an asset trades this far above its short-term averages, it signals a market driven by speculative buying rather than gradual accumulation.
However, the daily RSI14 at 81.43 is deep in overbought territory. This is the kind of reading typically seen near local tops, not mid-trend. It does not guarantee the move is over, but buyers are paying an increasingly steep premium to stay long. The MACD confirms the bullish momentum, with the line at 54.76 well above the signal at 30.9 and a positive histogram of 23.86.
That said, the Bollinger Bands tell a similar story from a volatility angle. Price sits against the upper band at $302.12, with the midline all the way down at $124.24. That is an extreme standard-deviation move away from the mean. ATR14 at $45.78 confirms daily ranges have widened significantly. Daily pivots place the pivot point at $293.60, with resistance at $303.19 and support at $284.54. The next directional push through either R1 or S1 will likely define the next few sessions.
1H Timeframe: Momentum Starts to Lean the Other Way
The hourly chart reveals that short-term momentum has already begun to fade even while the broader uptrend remains intact. Price at $294.56 still holds above EMA20 at $290.89 and EMA50 at $276.37, but RSI14 has cooled to 55 — essentially neutral, a significant step down from the daily’s 81.43.
This is where the Quant QNT crypto divergence becomes most visible. The gap between daily and hourly RSI signals that the broader move has outpaced the short-term buying pressure needed to sustain it without a pause. Moreover, the hourly MACD confirms the tension: the line sits at 3.5851 against a signal of 5.0326, producing a negative histogram of -1.4475. This bearish crossover means short-term momentum has rolled over even while the broader structure holds.
Hourly Bollinger Bands place the midline at $295.03, almost exactly where price trades, with the upper band at $310.31 and lower at $279.75. Price sitting on the mid-band after such an extended daily move suggests the market is in a holding pattern. Hourly pivots show support at $287.24 and resistance at $298.67 — a tight range likely to dominate the next several hours.
15-Minute View: Execution Context
The 15-minute chart confirms what the hourly already suggests: momentum has stalled, and the market is holding in a tight, indecisive range. QNT trades at $294.90, just above its EMA20 at $292.75 and EMA50 at $292.67, with RSI14 at 53.24 — once again neutral. The MACD here is also negative, with the line at -0.19874 below a signal of -0.0048308.
Consequently, short-term momentum has lost its edge even as price holds above the micro moving averages. This timeframe is not useful for calling direction. It is mainly useful for spotting entries or exits around the $292.48 support and $296.13 resistance pivots, inside an otherwise tight and indecisive range.
Bullish Scenario
A bullish continuation requires buyers to defend the hourly EMA20 near $290.89 and push through two key levels: the hourly resistance at $298.67 and then the daily R1 at $303.19. If that happens, the stretched daily trend gets a fresh leg of confirmation and the parabolic structure extends rather than breaks.
Furthermore, a reclaim of the upper daily Bollinger Band around $302 would support the continuation thesis. This scenario would be invalidated if price fails to hold above the hourly EMA50 at $276.37 or loses the 15-minute EMA200 near $281.10. Either of those breakdowns would flip the short-term structure bearish and undercut the case for an immediate breakout.
Bearish Scenario
Given the daily RSI at 81.43 and price pressed against the upper Bollinger Band, a pullback is a reasonable mean-reversion scenario. The daily S1 at $284.54 and the hourly lower band at $279.75 represent realistic downside targets. The hourly MACD’s bearish crossover and the cooling RSI across both the 1H and 15-minute charts support the idea that momentum needs to reset before any further advance.
This bearish case would be invalidated by a strong reclaim of the daily R1 at $303.19 together with a push above the hourly upper band at $310.31. That combination would argue the trend is simply too strong to fade, forcing bears to step aside.
Positioning and Risk Context
The broader market data reinforces QNT’s overbought profile: total crypto market cap is cooling while the token pushes higher on its own momentum. According to CoinGecko, the total crypto market cap sits around $2.89 trillion, down 1.83% over the past 24 hours, with Bitcoin dominance at 58.3%. QNT pushing higher while the wider market cools slightly suggests the token has been trading on its own momentum rather than riding a broad risk-on wave.
Meanwhile, the Fear & Greed Index reading of 74, classified as Greed, lines up with the overbought daily RSI. It reinforces the idea that sentiment around the token has become quite stretched on the retail and momentum-trading side. None of this guarantees a specific outcome. What the multi-timeframe picture actually shows is a daily trend that remains structurally bullish but runs on momentum already fading on shorter timeframes.
This setup typically resolves into either a sharp continuation or a volatile consolidation, rarely a quiet one. ATR readings across daily and hourly charts confirm that ranges have widened considerably. Whichever direction this resolves in, the moves are likely to be fast. Anyone tracking this pair should watch the hourly EMA50 and the daily pivot zone closely, since those levels are where the next real decision point is likely to show up.
FAQ
What is the current price of Quant?
As of October 1, 2026, QNT/USDT trades at approximately $294.12 on Binance, according to daily chart data. The token sits well above all major moving averages after an extended rally.
Is Quant QNT overbought right now?
Yes, the daily RSI14 stands at 81.43, which is deep in overbought territory. Readings above 70 are typically associated with local tops rather than mid-trend continuation, though they can persist during strong parabolic runs.
What are the key support and resistance levels for QNT?
Key support sits at the daily S1 of $284.54 and the hourly lower Bollinger Band at $279.75. On the upside, resistance is found at the hourly pivot of $298.67 and the daily R1 at $303.19, with the upper daily Bollinger Band at $302.12 adding reinforcement.
What does the multi-timeframe analysis suggest about QNT’s next move?
The daily trend remains structurally bullish, but the hourly MACD shows a bearish crossover and the 1H RSI has cooled to neutral at 55. This divergence suggests momentum needs to reset, making either a sharp continuation or a volatile consolidation the most likely near-term outcomes.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

As of October 1, 2026, Jupiter crypto is trading at $0.3297, sitting almost exactly on its daily pivot point after a multi-week advance above every major moving average. That positioning marks a decision point where the longer-term trend is clear but shorter-term charts tell a quieter, more hesitant story.
JUP/USDT — daily chart with candlesticks, EMA20/EMA50 and volume.
Key takeaways
JUP trades at $0.3297, parked precisely on its daily pivot point as of October 1, 2026
The daily trend is firmly bullish with price above all major moving averages
Short-term charts show neutral to slightly bearish momentum on the 1H and 15m timeframes
Daily ATR near 9% of price means any directional break could travel fast
Fear & Greed Index at 74 reflects stretched but present risk appetite
Daily Trend: The Dominant Force Behind the Move
The daily chart for Jupiter crypto paints a decisively bullish picture. Price at $0.3297 stands above the EMA20 at $0.2992, the EMA50 at $0.25954, and the EMA200 at $0.21596, with generous spacing between each average. That wide separation is a classic signature of an entrenched uptrend rather than a fragile bounce, giving the trend real cushion if a pullback arrives.
RSI14 on the daily sits at 62.18, firmly on the bullish side of neutral without touching overbought territory. Buyers remain in control, yet there is still room before the move gets stretched. MACD confirms the read: the line at 0.028877 sits above the signal at 0.026882, with a positive histogram of 0.0019947. Momentum is still tilted upward, and nothing in the indicator set contradicts the bullish classification.
Hourly and 15-Minute: A Pause, Not a Reversal
The shorter timeframes reveal a market that has paused to digest rather than reversed. On the 1H chart, price at $0.3297 is wedged between the EMA20 at $0.32958 and EMA50 at $0.33024 — essentially flat, with no real separation between the averages. RSI14 at 50.17 is as neutral as it gets, and MACD is barely positive. That reads as indecision rather than conviction, confirming the neutral regime label on the 1H.
However, the 15-minute chart leans slightly bearish in the short term. EMA20 at $0.33021 sits just above EMA50 at $0.32987, but the EMA200 at $0.33082 stays above both — an inverted stack that typically appears after a recent pullback inside a larger range. RSI14 at 48.23 and a negative MACD histogram of -0.00023727 both point to fading short-term momentum. None of this breaks the daily uptrend; it simply means the immediate hours ahead are more about digestion than continuation.
Bollinger Bands and ATR: Room to Move, Volatility to Respect
Bollinger Bands show that JUP still has genuine room to run if buyers return to the table. On the daily chart, price runs above the mid-band at $0.28975 and remains well below the upper band at $0.37989. This is not a chart already stretched to its ceiling. Daily ATR14 at $0.02995, roughly 9% of current price, confirms that JUP has been moving with real conviction and that any breakout or breakdown could travel quickly.
Meanwhile, on the 1H chart, the bands have tightened noticeably: the mid-band sits at $0.32976, the upper at $0.33656, and the lower at $0.32295. ATR14 has compressed to 0.0047429, signaling that short-term volatility has contracted exactly as price consolidates near the pivot. Compression after a strong daily run often sets the stage for the next directional push, though it can resolve in either direction.
Pivot Levels: The Battle Line Near $0.3297
What makes this moment unusual is how tightly the pivots align across timeframes. The daily pivot sits at $0.32987 with resistance at $0.33333 (R1) and support at $0.32623 (S1). The 1H pivot is nearly identical at $0.32987, with R1 at $0.33113 and S1 at $0.32843. The 15m pivot comes in at $0.32967. Price is effectively parked on top of all three pivots simultaneously, which explains why shorter-term charts feel so undecided — the market has not yet picked which side of this level to commit to.
Bullish Scenario for JUP
A breakout above the daily R1 at $0.33333 would align the short-term charts with the dominant daily trend and likely trigger a move toward the upper Bollinger Band near $0.37989. For that scenario to unfold convincingly, the hourly RSI needs to climb back above 55-60 and the 1H and 15m MACD histograms must flip and stay positive. Right now they are too weak to confirm a breakout on their own. A reclaim of the hourly EMA50 at $0.33024 with volume would be the first sign that buyers are back in charge on the shorter timeframes.
Bearish Scenario for JUP
Conversely, the alternative path is a mean-reversion move back toward the daily EMA20 at $0.2992, which would still leave the broader uptrend technically intact since that average has served as dynamic support throughout the rally. The trigger would be a clean break below the daily S1 at $0.32623, especially if accompanied by 1H RSI sliding under 40 and MACD histograms staying negative across both lower timeframes. A deeper warning sign would only arrive if price eventually threatened the EMA50 at $0.25954 — that is the level that would actually put the daily bullish structure in question.
Positioning, Risk and What to Watch
JUP’s trend has paused to catch its breath precisely where it needed to — at a pivot cluster that every timeframe agrees on. The daily chart indicates the path of least resistance is still up; the hourly and 15-minute charts indicate nobody has forced the next move yet. That disagreement is not a flaw in the analysis — it is the actual state of the market. Traders should treat the zone around $0.3297-$0.3299 as the line that decides which read wins out in the next few sessions.
Moreover, with daily ATR still running near 9% of price, moves in either direction can happen quickly once a direction is chosen, so position sizing and stop placement matter more than usual. The broader backdrop — total crypto market cap near $2.89 trillion, Bitcoin dominance at 58.3%, and a Fear & Greed reading of 74 — adds another layer of uncertainty. Sentiment is greedy enough to fuel a breakout, but also stretched enough that a sharp pullback in risk appetite would not be shocking. This is a market to watch closely rather than chase blindly.
FAQ
What is the current price of JUP?
As of October 1, 2026, JUP is trading at $0.3297, sitting almost exactly on its daily pivot point after an extended multi-week rally.
Is JUP in a bullish or bearish trend right now?
The daily trend is firmly bullish. Price trades above all major moving averages, RSI14 sits at 62.18, and the MACD remains in positive territory with no signs of divergence.
What are the key support and resistance levels to watch?
The daily pivot at $0.32987 is the central battle line. Resistance sits at $0.33333 (R1), while support rests at $0.32623 (S1). The upper Bollinger Band near $0.37989 serves as a longer-term target, and the daily EMA20 at $0.2992 acts as dynamic support.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

MetaMask began pulling Ethereum validators out of service on September 30, 2026, after flagging a security incident inside part of its infrastructure. The MetaMask Ethereum validator exit is now running on a tight clock, with Lido, the staking protocol hosting the affected validators, expecting the last of them to complete their exit by October 7, 2026. The company says there is no sign that MetaMask wallets themselves are at risk, but the episode is a reminder of how quickly a problem at one infrastructure layer can ripple through the staking ecosystem.
Key takeaways
MetaMask is proactively exiting Ethereum validators run through its non-custodial staking business following a security incident disclosed on September 30, 2026.
Lido expects the final affected validators to exit by October 7, 2026, with the full exit-withdrawal-re-entry cycle possibly stretching to about 45 days.
MetaMask says it has detected no immediate threat to its wallets and does not control clients’ withdrawal keys, meaning it cannot move stake on its own.
Lido says no action is required from stETH holders, though affected validators may forfeit rewards or face downtime penalties.
Aave founder Stani Kulechov says Aave’s markets remain unaffected and are operating normally during the investigation.
MetaMask Exits Ethereum Validators After Security Incident
MetaMask is responding to an infrastructure-level security problem by exiting the validators it operates on behalf of staking clients, rather than by freezing wallet access or pausing its broader product. The company described the move as a precaution taken while it works with outside partners and security advisers to understand what happened.
Details of the Infrastructure Compromise
On September 30, 2026, MetaMask posted a security update acknowledging it was “responding to a security incident affecting part of our infrastructure.” The statement did not name the systems involved, the attack method, or how many validators or how much ETH might be exposed. Lido‘s own disclosure on its governance forum similarly referred only to an “infrastructure compromise” at MetaMask Staking, the business formerly known as Consensys Staking. Both companies say a full investigation is underway and that more details will follow as the probe develops.
Impact on MetaMask Wallets and Client Stake
MetaMask has been careful to separate the compromised infrastructure from its wallet product, saying it has identified “no immediate threat to MetaMask wallets.” Crucially, the company’s staking operation is structured as non-custodial: MetaMask signs validator duties but does not hold the withdrawal keys tied to client stake. That means the operator cannot move the underlying ETH on a client’s behalf, even in a worst-case scenario. This distinction matters for anyone watching the MetaMask Ethereum validator exit unfold, because it draws a line between an operational infrastructure problem and a direct threat to user funds.
Lido’s Role and Timeline for Validator Exit
Lido is managing the practical side of the exit, and its disclosure gives the clearest picture so far of how long the process could take and what stETH holders can expect in the meantime.
Expected Completion Date and Withdrawal Cycle
According to Lido’s governance forum post, the protocol expects the final MetaMask-operated validators to reach the “exited” state by the end of October 7, 2026, though they won’t necessarily be fully withdrawn by that date. ETH will return gradually as each validator passes through exit, withdrawal, and eventual re-entry. Lido estimates the complete cycle could take up to roughly 45 days, a timeline driven largely by Ethereum‘s extended validator entry queue.
Operational Implications for stETH Holders and Validators
Lido has been explicit on one point: “No action is required from stETH holders.” Stakers don’t need to withdraw, swap, or otherwise react to the news. That said, the exit isn’t entirely free of cost. Affected validators may forgo staking rewards while out of service, and if operators take validators offline before the exit process formally completes, those validators could face downtime penalties. Lido attributed that possible step to efforts to limit exposure to network penalties, not to any confirmed slashing event.
Operational Risks and Historical Context of Large Validator Exits
Large-scale validator exits aren’t new to Lido, and the protocol’s track record offers some perspective on what’s realistically at stake here.
Potential Downtime Penalties and Reward Forfeiture
The core risk tied to this incident is financial rather than existential: missed rewards and possible downtime penalties, not a confirmed loss of funds. According to Lido’s security disclosure, these are predictable expenses tied to a cautious withdrawal; the disclosure cites a node-operator network that has grown to over 600 participants alongside an ad hoc reserve of more than 6,750 stETH set aside specifically to cushion disruptions of this nature.
Precedent Cases and Ethereum Validator Queue Impact
This isn’t the first time a staking operator tied to MetaMask’s current infrastructure has had to exit validators under pressure. Back in September 2025, the staking provider Kiln pulled 5,726 validators from several networks after an attacker exploited a compromised GitHub token to breach its systems; Lido subsequently calculated that the incident resulted in roughly 207 ETH in forfeited protocol rewards, though no actual protocol exploit was confirmed. Earlier still, back in 2023, this same operator—at the time operating under the ConsenSys brand—accidentally pulled 125 Lido validators out and reimbursed impacted stakers for the rewards they lost as a result. Neither precedent proves this incident will resolve the same way, but both show that large validator exits tend to produce reward costs and logistical delays rather than direct fund losses. Ethereum’s validator entry queue remains the main variable determining how fast exited stake can become active again.
Why this matters beyond MetaMask: stETH and similar staking derivatives are deeply embedded across decentralized finance, including lending markets. Aave founder Stani Kulechov said he was monitoring the situation alongside developments at Lido and confirmed that Aave’s markets had not been affected, with the protocol continuing to operate normally. That reaction suggests the broader DeFi ecosystem is, for now, treating this as a contained infrastructure event rather than a systemic risk — though the full scope of what was compromised at MetaMask still isn’t public.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

The Zcash community has approved roughly $8.39 million in retroactive grants, a decision aimed at compensating the developers and security researchers who scrambled to fix a critical vulnerability in the network’s Orchard protocol. Zcash co-founder Zooko Wilcox confirmed the outcome of the vote, which covered 17 separate funding proposals tied to the bug fix and the broader Ironwood upgrade effort.
Key takeaways
The Zcash community approved approximately $8.39 million in retroactive grants across 17 proposals.
The funds compensate developers and security researchers who discovered and fixed a critical vulnerability in the Orchard protocol.
Grants also cover auditing work and delivery of the Ironwood upgrade.
About 2.18 million ZEC tokens took part in the governance vote.
Zcash co-founder Zooko Wilcox publicly confirmed the grant approval.
Zcash Community Approves Retroactive Grants
The vote marks one of the largest coordinated funding decisions in Zcash‘s recent governance history, directing money toward work that was already done rather than work still to be completed. That distinction matters: retroactive grants reward people who acted before formal compensation was guaranteed, which is a notable signal about how the network treats emergency security response.
Summary of the Vote and Financial Approval
Community data show that 17 proposals totaling about $8.39 million were approved in the latest round. Wilcox said the vote approved “more than $8 million in retroactive grants,” a figure that lines up closely with the community-reported total. The size of the payout underlines how seriously the network treated the underlying security issue.
Scope and Purpose of the Grants
Wilcox noted that several million dollars of the approved funding are specifically set aside for developers and security researchers who helped discover and fix the Orchard vulnerability. The remaining allocations cover auditing the affected code and delivering the Ironwood upgrade, which appears to be tied to the same remediation effort. In practice, this means the grants span the full lifecycle of the response: finding the bug, patching it, verifying the fix through audits, and shipping the resulting upgrade.
This matters beyond the Zcash ecosystem too. A protocol-level security flaw in a privacy-focused blockchain carries higher stakes than in many other networks, since the entire value proposition of Zcash rests on cryptographic guarantees around shielded transactions. Compensating the people who caught and resolved the issue reinforces incentives for fast, transparent disclosure rather than quiet patching.
Details of the Voting Process
The grant decision was settled through an on-chain governance vote rather than a centralized allocation, with participation levels giving a sense of how engaged the ZEC holder base was on this particular question.
Number of Proposals and Participation
The vote involved 17 proposals in total, each presumably tied to a specific contributor, team, or category of work related to the Orchard fix and the Ironwood rollout. Around 2.18 million ZEC tokens participated in the voting process, giving the result a measurable base of community support rather than resting on a handful of large holders alone.
Community Governance in Action
The structure of the vote, spanning multiple proposals rather than a single up-or-down question, suggests the community weighed individual contributions separately before reaching a combined total near $8.39 million. This kind of itemized approach allows token holders to assess each piece of funded work on its own merits, which can matter when a grant request touches sensitive technical territory like a security vulnerability.
Statements from Zcash Leadership
Zooko Wilcox’s confirmation puts an official voice behind numbers that were otherwise emerging from community-tracked data.
Co-founder Zooko Wilcox Highlights Grant Approval
According to Wilcox, the community’s latest vote greenlit retroactive grants totaling more than $8 million, covering developers and security researchers linked to the Orchard vulnerability along with funds for code audits and the Ironwood upgrade rollout. His statement effectively ties the financial outcome directly to the technical remediation work, framing the grants as recognition for addressing a critical security bug in the Orchard protocol rather than as a general development fund.
For a network built around financial privacy, how it handles and funds the response to a vulnerability like this becomes part of its credibility story. The retroactive nature of the payout, covering work already completed around the Orchard fix and Ironwood delivery, signals that the Zcash community treated the bug as urgent enough to act first and formalize compensation afterward through its governance process.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

Google has pulled back the curtain on Gemini 4 Argon, a new flagship AI model the company says outperforms its predecessors in software engineering, enterprise knowledge work, and cybersecurity defense. Alphabet rolled out the system on Wednesday, September 30, 2026, starting with a limited group of trusted cyber partners rather than a full public launch. The move marks the company’s biggest step yet toward what it calls frontier-level intelligence, and it lands at a moment when Google is under pressure to prove its models can match rivals on real-world, high-stakes tasks.
Key takeaways
Gemini 4 Argon AI expands its output token limit to 1 million tokens, up from 64,000, allowing far longer reasoning chains.
The model sets a new state of the art on DeepSWE v1.1 with a 77.9% score for long-horizon software engineering tasks.
Argon ties for first place on CWE-bench v1 with a 68% score, building on the cybersecurity groundwork laid by Google’s 3.8 Flash Cyber model.
Internal deployments have already freed over 300 TiB of data center memory, with total estimated savings between 500 TiB and 1 PiB.
Google is releasing Argon in phases, starting with cybersecurity partners.
Gemini 4 Argon’s Frontier Performance Across Software Engineering and Enterprise Work
Gemini 4 Argon delivers what Google describes as frontier performance in complex, real-world workflows spanning coding, legal and financial research, and security defense. The company says the model is already running inside its own engineering teams, with staff citing gains in specialized coding tasks, deeper research capability, and writing quality.
Benchmark Scores That Set New Standards
On DeepSWE v1.1, a benchmark measuring long-horizon, real-world software engineering performance, Argon posted a score of 77.9%, a new state of the art according to Google. Beyond coding, the model tops the Vals Index, which tracks economic impact across finance, coding, legal, and tax work, weighting each sector by its contribution to U.S. GDP. CNBC reported that Argon lands ahead of OpenAI’s GPT-6 Astra and Anthropic’s Fable 5.1 on that same index. The model also ranks first on Zapier’s AutomationBench, which measures end-to-end execution across core business functions, with a score of 51.3%, and hits 91.7% on LVBench, a test of long video understanding, which Google calls state of the art. Argon’s strength in visual reasoning also extends to professional chart analysis and document-based decision-making, useful for knowledge workers who juggle dense reports and multi-page filings.
This spread of results matters because it shows the model isn’t just a coding specialist. A system that performs well on legal drafting, financial research, and video comprehension at once suggests Google is aiming Argon at enterprise customers who need one model across multiple departments, rather than a patchwork of narrow tools.
Cybersecurity Defense and the Wiz Collaboration
Argon was specifically trained to strengthen cyber defense, and Google says it can autonomously find, validate, and patch critical software vulnerabilities. On CWE-bench v1, which evaluates a model’s ability to remediate security flaws, Argon ties for first place with a top score of 68%, building on the performance of Google’s 3.8 Flash Cyber model, which was released earlier in September 2026 and led CWE-bench v0. CNBC reported that Argon also ties with OpenAI’s GPT-6 Astra and Grok 4.7 on cybersecurity evaluation benchmarks, positioning it as a direct competitor in a fast-moving corner of the AI race.
For trusted defenders and Google’s internal teams, the company plans to release Argon without cyber guardrails, giving them access to the model’s full frontier-level defensive capabilities.
Autonomous Vulnerability Discovery in Action
Security firm Wiz is already putting Argon to work through its Scan for Good initiative, a free program aimed at protecting critical public infrastructure by finding and fixing high-risk exposures. In an early test, the model uncovered a critical vulnerability exposing sensitive personal information across healthcare software used by hospitals worldwide — a risk that Google says previous frontier models had missed entirely. On Google’s internal vulnerability benchmark, Argon surfaced exposures across codebases spanning 20 programming languages, and on Wiz’s black-box penetration testing benchmark, it outperformed 3.8 Flash Cyber at identifying attack surfaces and producing proof-of-concept evidence.
Technical Innovations: From Million-Token Outputs to Quantum Optimization
To support longer and more complex tasks, Google significantly expanded Argon’s output token limit to an industry-leading 1 million tokens, up from the previous 64,000. That extra headroom lets the model generate hundreds of thousands of tokens in a single reasoning pass, adding depth to problems that once required multiple back-and-forth sessions.
The model is already producing measurable results inside Google’s own infrastructure. In quantum computing research, Argon helped optimize the spacetime resources — qubits multiplied by gates — of subroutines that bottleneck key applications, beating a published baseline by 40% in a matter of minutes. Separately, a team of Argon agents analyzed fleet-wide telemetry across Google’s data centers to autonomously identify and apply memory optimizations, freeing more than 300 TiB of memory once fully rolled out, with total estimated savings between 500 TiB and 1 PiB — gains CNBC noted came without the company buying additional hardware.
Argon agents are also tackling one of software engineering’s more tedious jobs: migrating C/C++ codebases to Rust. The effort spans tens of thousands of lines in core libraries like re2 and libgav1, scaling up to more than 800,000 lines for the Fuchsia OS Zircon kernel. Given how critical these systems are, Google says the rewrites go through rigorous automated and manual auditing, emulation testing, and review before reaching production. For libgav1, Google’s open-source video decoding library, Argon agents took an existing Rust port and replaced 32,000 lines of SIMD code through repeated profile-guided experiments, producing a memory-safe decoder that runs 2.7 times faster than the earlier Rust version while matching identical video output.
Frontier Safeguards Before Broader Availability
Before Argon reaches a wider audience, Google says it is strengthening safeguards. The model is designed to refuse harmful requests tied to cyber or CBRN (chemical, biological, radiological, nuclear) misuse while still supporting legitimate dual-use scientific research, under the company’s Frontier Safety Framework. Google says it has improved techniques for monitoring the model’s internal activations to catch misuse, with the safeguards tested by internal and external red teams using manual and automated attack methods.
Argon is also described as Google’s most resilient model yet against indirect prompt injection attacks, where hidden instructions try to hijack a model’s behavior. Through adversarial training and automated red teaming, the company says Argon leads on Gray Swan’s Indirect Prompt Injection benchmark.
This layered approach reflects a broader tension in frontier AI development: the same capabilities that make a model useful for finding and patching vulnerabilities could, in the wrong hands, be turned toward discovering new ones. Google’s decision to release Argon first to a narrow group of trusted cybersecurity partners, rather than the public, signals how seriously it’s treating that dual-use risk.
Rollout Strategy and What Comes Next
Google is not flipping the switch on Argon all at once. The company says it plans to release the model in phases, beginning with an initial cohort of cyber defenders and trusted testers whose real-world feedback will help refine the system before it reaches developers, enterprises, and consumers.
CNBC also reported that Google is running a pre-release safety evaluation with the U.S. government as part of the rollout. The timing is notable: the launch came a day after Google CEO Sundar Pichai signed a voluntary AI safety accord with President Donald Trump, following a meeting with major tech executives at the White House focused on rising concerns over AI safety.
The launch also marks a shift in strategy. According to CNBC, Google spent much of the past year scaling faster, lower-cost “flash” models, while Gemini 4 Argon represents a renewed push at the frontier — arriving nearly a year after Gemini 3 put the company back at the front of the AI model race. Whether Argon can hold that position will depend less on benchmark scores and more on how it performs once it’s in the hands of outside developers and enterprise customers who weren’t part of Google’s internal testing.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

United Therapeutics stock is having a violent session. Shares were trading at $540.54 as of 14:20 ET on Wednesday, September 30, up 12.27% versus the previous close of $481.47 on September 29. That is an unusually large swing for a biotech that Wall Street generally treats as a steady cash-flow story, and it deserves a closer look before anyone assumes the trend is simply continuing.
UTHR — daily chart with candlesticks, EMA20/EMA50 and volume.
Key takeaways
United Therapeutics stock surged 12.27% intraday, trading at $540.54 as of 14:20 ET on Wednesday, September 30, with volume at 148,921 shares.
No company-specific news in the current flow explains the spike; the move’s trigger is not documented in available headlines.
The daily RSI at 65.38 remains below overbought territory, but the hourly RSI at 78.94 signals deeply stretched conditions.
Goldman Sachs initiated coverage with a Sell rating and a $321 price target on September 24, while Seeking Alpha and Yahoo Finance argued the stock was undervalued.
Price is trading above the daily Bollinger upper band at $522.47, marking a genuine breakout beyond the normal daily volatility envelope.
No company-specific news in the current flow explains today’s spike. The most recent headlines are two to four days old and center on Goldman Sachs’ Sell initiation and a subsequent 4% drop, not on anything dated to this session. So while the move is real and visible on every timeframe, its immediate trigger is not documented in the available news, and the rest of this analysis stays technical.
Because the daily move reached 12.27%, volume is worth flagging: today’s volume differs by timeframe, with the daily candle showing 148,921 shares, the hourly candle showing 11,964 shares, and the most recent 15-minute candle showing 699 shares, each reflecting a different slice of the same still-open session.
United Therapeutics Stock: Daily Chart Stretched to Extremes
The daily chart shows United Therapeutics stock stretched well beyond its normal volatility envelope. Today’s candle dwarfs the 14-day ATR of $17.94, underlining just how abnormal this session is relative to recent history.
Today’s daily candle opened at $484.99, swung between a low of $476.47 and a high of $555.59, and is currently marking $540.54. Price is sitting above all three daily moving averages — the 20-session EMA at $498.38, the 50-session EMA at $509.47, and the 200-session EMA at $500.88. However, the averages themselves are not stacked in a clean bullish order. The 50-session EMA sits above the 200-session EMA, which in turn sits above the 20-session EMA. In practice, the longer-term trend structure has not yet caught up to today’s spike.
The daily RSI at 65.38 shows building bullish momentum without reaching extreme overbought territory. MACD tells a more nuanced story: the line at -3.81 remains below zero, but it now sits above the signal at -6.81, and the histogram has turned positive at 3.01. That is a bullish crossover forming. However, it is emerging from a negative MACD backdrop, which reads as momentum turning up rather than an established uptrend.
Meanwhile, the Bollinger setup adds weight to the overextension argument. The daily upper band sits at $522.47, and price at $540.54 is trading well above it. That is a genuine breakout above the normal daily volatility envelope, not a routine push toward resistance. The daily pivot point at $524.20 has been cleared. Price is now working toward the r1 level at $571.93, while s1 at $492.81 sits far below current levels.
Hourly Momentum Confirms the Move, But Overbought Warnings Mount
The hourly chart confirms the breakout with strong MACD readings. However, an RSI at 78.94 warns that United Therapeutics stock is deeply overbought on this timeframe.
The latest hourly candle ran from $546.09 down to $540.54, having earlier touched $548.19, suggesting some fading of the immediate push. Hourly EMAs show the 200-hour average at $499.99 above the 20-hour at $498.96. The 20-hour in turn sits above the 50-hour at $491.59 — again, not a textbook bullish stack, but price is comfortably above all three.
Notably, RSI on the hourly chart reads 78.94, firmly in overbought territory. At the same time, MACD is unambiguously bullish here. The line at 12.74 sits well above the signal at 4.78, and the histogram reads 7.96 — stronger and more decisive than the daily reading. The hourly Bollinger upper band sits at $538.97, and price at $540.54 is just above it. This is another sign of a market pushing beyond its normal short-term range.
On the pivot side, the hourly pivot point at $542.91 currently sits just above the last price, with s1 at $537.63 acting as nearby support. In other words, price has pulled back slightly from the session’s intraday highs. It is now consolidating just below its own pivot — a detail that matters for anyone timing entries rather than reading the broader trend.
15-Minute Execution: Consolidation Near the Pivot
The 15-minute chart presents the cleanest bullish structure across all timeframes. Yet United Therapeutics stock is consolidating near the pivot rather than extending higher, with MACD showing fading thrust.
Here, the EMAs are properly stacked bullish. The 20-period average at $525.32 sits above the 50-period at $504.37, which sits above the 200-period at $491.63. Price at $540.54 trades above all three, confirming the short-term uptrend is technically intact.
Meanwhile, RSI at 68.79 shows healthy bullish momentum without extreme stress. Notably, MACD on this timeframe tells a story of fading thrust. The line at 16.79 is barely above the signal at 16.05, and the histogram has thinned to just 0.75. That flattening suggests the sharpest burst of buying may already be behind this particular leg, even as the broader structure remains bullish.
Unlike the daily and hourly charts, price on the 15-minute chart sits comfortably inside its Bollinger bands. The mid sits at $519.66 and the upper band at $580.39. This is a meaningful contrast. The shorter timeframe is absorbing the move calmly, while the daily and hourly charts show price stretched beyond their own volatility envelopes. The 15-minute pivot point at $540.79 is essentially where price is trading now. It is boxed between s1 at $539.76 and r1 at $541.58 — a tight, indecisive range that points to short-term consolidation rather than an immediate continuation.
A Divided Wall Street Adds Context
Wall Street is genuinely split on United Therapeutics stock. Goldman Sachs issued a Sell call at a $321 price target, while Seeking Alpha and Yahoo Finance argued the stock remains undervalued.
The technical picture is unfolding against a backdrop of genuine analyst disagreement. Goldman Sachs analyst Andrea Newkirk initiated coverage on September 24 with a Sell rating and a $321 price target, arguing that shares trade above their historical valuation range while the core franchise shrinks. However, the firm reportedly still sees real catalysts arriving in 2027. That call reportedly sent the stock down 4% in the following session, according to a Yahoo Finance report — a move that predates today’s rally and should not be confused with it.
On the other hand, a Seeking Alpha piece published the same week argued for a Buy rating. It contended that the erosion investors are focused on sits within roughly 32% of the business, while tax-normalized earnings power stands at $1.05 billion. A separate Yahoo Finance article framed the post-Goldman decline as a buying opportunity, citing a claim that shares were still 29% undervalued — a figure attributed to that outlet’s own analysis. Separately, an Investing.com report noted that United Therapeutics’ chairperson and CEO sold $4.7 million in stock. This adds a layer of insider-selling context to the broader valuation debate, though it does not explain today’s price action either.
Bullish Scenario: Room to Extend Toward $571
The bullish case for United Therapeutics stock hinges on holding above the daily pivot at $524.20. That would keep the path toward r1 resistance at $571.93 open.
For bulls, the case rests on follow-through above the breakout levels already reached. A sustained move above the daily Bollinger upper band near $522.47, rather than a quick reversal back inside it, would support the idea that this is a genuine repricing rather than a one-day spike.
On the hourly chart, bulls would want to see price reclaim and hold above the pivot at $542.91 without breaking the s1 support at $537.63. Therefore, a reacceleration of the 15-minute MACD histogram — currently thin at 0.75 — back toward expansion would be the clearest short-term signal that buying pressure is resuming rather than fading into consolidation.
Bearish Scenario: Mean Reversion Risk Builds
The bearish case centers on how stretched United Therapeutics stock already looks. An hourly RSI of 78.94 sits deep in overbought territory, and price trades above upper Bollinger bands on both the daily and hourly charts simultaneously.
Historically, that combination raises the odds of a mean-reversion pullback, even within an otherwise constructive trend.
Still, a loss of the hourly pivot at $542.91 followed by a break below s1 at $537.63 would be an early warning sign. If that gives way, a retracement toward the daily EMA cluster between the 200-session average at $500.88 and the 50-session average at $509.47 becomes a realistic target.
A deeper slide back under the daily Bollinger mid at $495.22 and the 20-session EMA at $498.38 would undercut the bullish case built on today’s spike entirely. The daily EMA structure never confirmed a clean stacked uptrend in the first place. Goldman’s $321 price target, while not a technical level, remains a notable bearish anchor for anyone weighing valuation against today’s price.
Closing Take
Overall, United Therapeutics stock is caught between a powerful intraday breakout and a set of overbought readings that typically precede at least a partial pullback. The daily and hourly charts show price pushing beyond its normal volatility bands. Meanwhile, the 15-minute chart — calmer and more orderly — suggests the immediate momentum may be pausing rather than extending. Wall Street itself remains split, with Goldman’s Sell call and a $321 target sitting against Seeking Alpha’s Buy thesis and claims of meaningful undervaluation.
In this environment, volatility is the dominant fact, not direction. Positioning around such a stretched move carries real risk in both directions. With no fresh company-specific catalyst confirmed for today’s session, the next few sessions — and whether price can hold above levels like the daily pivot at $524.20 or the hourly pivot at $542.91 — will likely say more than today’s single candle can.
FAQ
What caused United Therapeutics stock to jump over 12% today?
No company-specific news in the current flow explains the spike. The most recent headlines are two to four days old and center on Goldman Sachs’ Sell initiation and a subsequent 4% drop. The move’s immediate trigger is not documented in available news.
What is the bullish scenario for United Therapeutics stock?
The bullish case hinges on holding above the daily pivot at $524.20, which would keep the path toward r1 resistance at $571.93 open. Bulls would also want to see price reclaim the hourly pivot at $542.91 without breaking s1 support at $537.63.
What are the key overbought warnings?
The hourly RSI at 78.94 sits firmly in overbought territory. Price is trading above the upper Bollinger bands on both the daily and hourly charts simultaneously — a combination that historically raises the odds of a mean-reversion pullback.
What is Goldman Sachs’ position on United Therapeutics stock?
Goldman Sachs analyst Andrea Newkirk initiated coverage with a Sell rating and a $321 price target on September 24, arguing shares trade above their historical valuation range while the core franchise shrinks. The call reportedly sent the stock down 4% in the following session.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

Albertsons Companies stock (ACI) was trading at $11.675 as of 14:21 ET on Wednesday, September 30, 2026, up 0.3% from the prior close of $11.64. The marginal gain does not alter the broader bearish structure, with price remaining well below every major moving average.
ACI — daily chart with candlesticks, EMA20/EMA50 and volume.
Key takeaways
Albertsons Companies stock trades at $11.675, remaining in a bearish structure below all major moving averages.
The daily RSI at 40.43 and negative MACD confirm that downside momentum remains intact.
The $11.54–$11.82 zone is the immediate battleground, with the broader trend still favoring bears.
Hourly momentum shows a tentative pause, but no reversal signal has yet emerged.
Daily ATR14 of $0.36 points to moderate volatility, keeping the pivot zone as the critical area to watch.
Daily Trend: Bearish Alignment Still in Control
No company-specific news accompanies today’s session. The analysis below leans entirely on price structure, momentum, and volatility.
Moving Average Stack and Momentum
On the daily timeframe, price at $11.675 sits below the 20-session EMA at $12.05. That EMA sits below the 50-session EMA at $12.52, which in turn sits below the 200-session EMA at $14.94. This is a fully stacked bearish alignment: price under EMA20, EMA20 under EMA50, EMA50 under EMA200. It is about as clean a downtrend signature as a chart can show.
Momentum confirms the same story. The daily RSI reads 40.43, comfortably below the neutral 50 line without being deep into oversold territory. That leaves room for the decline to extend before any stretched reading forces a reaction. Meanwhile, the daily MACD line sits at -0.20, below its signal line at -0.14, with a histogram of -0.06. Both the line and the signal are negative, and the histogram confirms the bearish bias is still active rather than fading.
Volatility and Pivot Context
Volatility context comes from the Bollinger Bands. The mid-band stands at $12.14, the upper band at $12.94, and the lower band at $11.35. Price is trading in the lower half of the range, closer to the lower band than to the mid-line. This fits a market under pressure rather than one consolidating. The daily ATR14 stands at $0.36, a reasonable gauge of how much the stock can realistically swing session to session.
Pivot levels frame the near-term battle. The daily pivot point sits at $11.68, essentially where price is trading. Resistance stands at $11.82 (R1) and support at $11.54 (S1). Therefore, Albertsons Companies stock is effectively camped right on top of its own pivot. The next directional cue will likely come from whichever side gives way first.
Hourly Chart: A Pause, Not a Reversal
On the 1-hour chart, the structure is still bearish but less decisively so. Price at $11.68 sits just below the 20-hour EMA at $11.69. That EMA sits below the 50-hour EMA at $11.84, which in turn sits below the 200-hour EMA at $12.12. The result is the same bearish stacking seen on the daily chart, just compressed into a tighter range.
However, momentum on this timeframe tells a slightly different story. The hourly RSI reads 47.09, essentially neutral. The MACD histogram has turned marginally positive at 0.02, with the line at -0.04 above the signal at -0.06. This is a small but notable divergence. The hourly trend is still technically bearish, yet short-term momentum is no longer accelerating lower. In practice, this looks more like a pause inside the broader downtrend than an active continuation move.
The hourly Bollinger Bands show a mid-line at $11.66, an upper band at $11.79, and a lower band at $11.54. Price sits just above the mid-band. Combined with an ATR14 of $0.12, the hourly range has narrowed considerably compared with the daily picture. This is consistent with a market catching its breath rather than making a decisive move.
15-Minute Chart: Execution Context
Zooming into the 15-minute chart, the picture turns neutral. Price at $11.68 is essentially sitting on top of both the 20-period EMA at $11.67 and the 50-period EMA at $11.67. The 200-period EMA sits higher at $11.93. RSI reads 50.83, dead center. The MACD line and signal are both at 0.01 with a flat histogram of 0.00.
In short, the shortest timeframe shows indecision. The 15-minute pivot point sits at $11.67, with resistance at $11.68 and support at $11.67. This razor-thin range reflects a market waiting for a catalyst rather than committing to a direction. The context is useful only for timing entries around the pivot cluster near $11.67–$11.68, not for reading the broader trend.
Bullish Scenario for Albertsons Companies Stock
For a bullish case to gain traction, Albertsons Companies stock would need to reclaim the daily pivot at $11.68 with conviction. It would then need to push through the R1 level at $11.82. A clean move back above the 20-session EMA at $12.05 would be the first real sign that the bearish structure is loosening its grip.
On the hourly chart, a sustained push of the MACD histogram further into positive territory would help. RSI climbing meaningfully above 50 would also lend support. Together, these signals would suggest the current pause is turning into an actual recovery rather than a brief stall.
Bearish Scenario for Albertsons Companies Stock
The bearish case remains the path of least resistance given the daily alignment. A break below the daily support at $11.54 (S1) would open the door toward the lower Bollinger Band at $11.35. This would reinforce the downtrend that has kept price under the 20, 50, and 200-session EMAs.
If the hourly MACD histogram rolls back negative and RSI slips back under 47, the tentative stabilization would likely give way. Renewed selling pressure would then invalidate any early bullish attempt.
Closing Take on Albertsons Companies
Overall, the daily trend in Albertsons Companies stock remains bearish. Price is trapped beneath a fully stacked set of moving averages and momentum still leans lower. Meanwhile, the hourly chart introduces some nuance, showing a brief pause in downside momentum without yet confirming a reversal.
In contrast, the 15-minute chart offers only short-term noise around the pivot, useful for execution but not for conviction. With the ATR14 readings pointing to modest daily volatility of $0.36, traders should treat the $11.54 to $11.82 zone as the key battleground. The broader technical backdrop still favors caution over complacency.
FAQ
What is the current trend for Albertsons Companies stock?
The daily trend is bearish, with price below the 20, 50, and 200-session EMAs in a fully stacked alignment. The daily RSI at 40.43 and negative MACD confirm downside momentum remains intact.
What are the key levels to watch for ACI?
Support sits at $11.54 (S1) and the lower Bollinger Band at $11.35. Resistance lies at $11.82 (R1) and the 20-session EMA at $12.05. A break of either boundary would likely set the next directional move.
Is there any sign of a trend reversal?
The hourly chart shows a tentative pause in downside momentum, with the MACD histogram turning marginally positive and RSI near neutral. However, no reversal has been confirmed. The daily bearish structure remains in control.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

Zeta Global stock was trading at $31.69 as of 14:19 ET on Wednesday, September 30, 2026, up 9.43% from the prior close of $28.96. The rally lifts price above all major daily moving averages and reinforces a weeks-long bullish structure. Yet momentum signals across timeframes now point to overbought conditions.
ZETA — daily chart with candlesticks, EMA20/EMA50 and volume.
Key takeaways
Zeta Global stock surged 9.43% intraday to $31.69, moving above all major daily moving averages.
Daily EMA stacking — price above the 20-session EMA at $29.97, above the 50-session EMA at $28.06, above the 200-session EMA at $22.79 — confirms a textbook bullish trend.
The daily MACD histogram remains negative at -0.24 despite the price advance, signaling a momentum lag.
Hourly RSI14 reached 73.25 and the 15-minute RSI14 hit 84.42, indicating short-term overbought conditions.
No company-specific news accompanied the move, making the surge a purely technical event.
Zeta Global Stock Daily Chart: Uptrend Confirmed, But Momentum Lags
The daily chart confirms a bullish trend for Zeta Global stock: price sits above every major moving average with the EMAs stacked in textbook order. Price holds above the 20-session EMA at $29.97, which sits above the 50-session EMA at $28.06. Both in turn are well above the 200-session EMA at $22.79. This alignment leaves no ambiguity about the direction of the broader trend.
Meanwhile, RSI14 at 61.27 supports the picture without flashing exhaustion. It is firm but not stretched. However, the daily MACD tells a more cautious story. The MACD line sits at 0.43, below the signal at 0.67. That leaves a negative histogram of -0.24.
In practice, downside momentum has been building on a closing basis. Spot price is pushing toward fresh highs — a classic momentum lag. It deserves attention rather than alarm.
Price is also testing the upper Bollinger Band on the daily chart. The upper band sits at $32.24, the midline at $30.48, and the lower band at $28.72. Being this close to the upper band typically signals a stretched short-term move. Yet the broader trend remains intact. Daily ATR14 stands at $1.49, indicating volatility that can produce sharp intraday swings. The daily pivot sits at $30.87, with resistance at $32.55 (R1) and support at $30.02 (S1). These levels matter for the rest of this session and into Thursday.
Zeta Global Stock Hourly Chart: Trend Confirms, But Momentum Looks Stretched
Turning to the hourly chart, Zeta Global stock remains in an uptrend on both timeframes. The bullish stacking holds with price above the 20-hour EMA at $29.90, which sits above the 50-hour EMA at $29.84. Both are above the 200-hour EMA at $29.46. This tight alignment confirms that intraday strength matches the broader direction.
However, hourly RSI14 has climbed to 73.25, a clear overbought reading. The hourly MACD line at 0.40 remains above its signal at 0.05. That produces a positive histogram of 0.35 — momentum is still pushing higher, not yet rolling over. Notably, price has moved above the hourly upper Bollinger Band of $31.40. The midline sits at $29.49 and the lower band at $27.58. Trading above the upper band on an hourly basis often precedes consolidation, even within a healthy trend.
The hourly pivot at $31.61, with resistance at $31.81 and support at $31.49, frames a narrow battleground for the next few hours.
15-Minute Chart: Extreme Overbought Conditions
The 15-minute chart leans even further into overbought territory. RSI14 sits at 84.42, an extreme reading that typically accompanies short bursts of exhaustion. The MACD histogram has compressed to just 0.03. The MACD line at 0.61 sits barely above the signal at 0.58. Momentum on this timeframe is flattening after the sharp advance.
Meanwhile, price is hugging the upper Bollinger Band at $32.21. The 15-minute pivot at $31.70 sits near the last traded price. Resistance stands at $31.72 and support at $31.67. In short, the 15-minute tape looks stretched and directionless at the margin. That is typical after a fast intraday surge like this one.
Bullish and Bearish Scenarios for Zeta Global Stock
The bullish case for Zeta Global stock rests on the daily trend holding its structure. If price stays above the daily EMA20 at $29.97 and the daily pivot at $30.87, buyers retain control. A decisive break above daily R1 at $32.55 and the upper Bollinger Band at $32.24 would signal that the rally still has room. That holds especially if daily RSI stays inside the 55-70 band without rolling over.
In that scenario, hourly and 15-minute overbought readings would reflect a strong trend absorbing new buyers rather than a warning sign.
On the other hand, the bearish or corrective scenario would build from a rejection at current levels. A drop below the hourly pivot at $31.61 and support at $31.49 would signal that intraday buyers are losing conviction. Should price fall through the daily pivot at $30.87 and test S1 at $30.02, the near-term bullish thesis would weaken considerably.
A deeper slide toward the daily lower Bollinger Band at $28.72 would be more serious. Combined with a deepening negative MACD histogram, it would invalidate the bullish continuation case. Even then, the longer-term uptrend defined by the EMA200 at $22.79 would likely remain technically intact.
Context Beyond the Chart
No company-specific news accompanies today’s 9.43% surge in Zeta Global stock. However, several items have circulated in recent days. A Yahoo Finance report from September 24 noted the company’s super-scaled customer count reached 197 in Q2 2026. That extended seven straight quarters of growth. The same report added that the long-term pace is expected to moderate.
Another Yahoo Finance piece from the same week grouped Zeta Global among AI names to watch. It tied renewed investor interest to broader geopolitical dynamics following a Trump-Xi meeting. Meanwhile, Investing.com reported a Form 144 filing dated September 26 — a routine notice tied to a proposed securities sale. None of these items are linked by their sources to the intraday move. The surge remains, for now, a purely technical event.
Overall, Zeta Global stock presents a strong, well-aligned bullish trend running into short-term overbought conditions. The daily and hourly EMA stacking both favor buyers. Yet the daily MACD histogram remains negative. Extreme RSI levels on shorter timeframes suggest the tape is due for a pause or shallow pullback.
Given the daily ATR of $1.49, volatility alone could produce meaningful intraday swings around the pivot levels. Positioning here calls for discipline. The broader trend remains constructive. But immediate risk-reward looks less favorable after a near double-digit move in a single session.
FAQ
What is the current price of Zeta Global stock?
Zeta Global stock was trading at $31.69 as of 14:19 ET on Wednesday, September 30, 2026, up 9.43% from the prior close of $28.96.
Is Zeta Global stock in a bullish trend?
Yes. The daily chart shows a textbook bullish EMA stacking: price holds above the 20-session EMA at $29.97, which sits above the 50-session EMA at $28.06. Both are well above the 200-session EMA at $22.79. The hourly chart confirms the same alignment with price above all three hourly EMAs.
What are the key levels to watch on Zeta Global stock?
Key resistance sits at the daily R1 of $32.55 and the upper Bollinger Band at $32.24. Support levels include the daily pivot at $30.87 and daily S1 at $30.02. On the hourly chart, the pivot is at $31.61 with nearby support at $31.49.
Are there overbought signals on Zeta Global stock?
Yes. The hourly RSI14 has reached 73.25, while the 15-minute RSI14 sits at an extreme 84.42. The daily MACD histogram is negative at -0.24 despite the price advance, signaling a momentum lag. Price is also testing the daily upper Bollinger Band, which often precedes some consolidation.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

The Generation Essentials Group stock (TGE) surged in a dramatic volatility event on Wednesday. As of 14:17 ET on September 30, 2026, shares were trading at $1.495, up 80.12% from the prior close of $0.83. Volume exceeded 168,389,984 shares.
TGE — daily chart with candlesticks, EMA20/EMA50 and volume.
Key takeaways
TGE shares surged 80.12% intraday, trading at $1.495 as of 14:17 ET on September 30, 2026, on volume of 168.39 million shares.
Daily RSI14 hit 85.95, deep in overbought territory, while price traded well above the upper Bollinger Band at $1.18.
The hourly chart shows a fully aligned bullish EMA stack, but hourly RSI14 at 82.82 also signals overbought conditions.
The 15-minute chart shows momentum stalling, with MACD turning slightly negative and RSI easing to 60.58.
A break below the daily pivot at $1.46 would open the door to a retracement toward S1 at $1.03, while a push above hourly R1 at $1.62 targets daily R1 at $1.93.
The Generation Essentials Group Stock Price Action: An Extreme Intraday Move
TGE is experiencing an extreme volatility expansion far beyond its normal range. Notably, no company-specific news accompanies this session’s action. Therefore, the move must be read through price structure, momentum and volatility alone.
On the daily chart, price pushed from an open of $1.04 to an intraday high of $1.90, against a low of $0.99. That range is unusually wide next to the stock’s typical daily volatility. ATR14 sits at just $0.12, underscoring how far today’s swing exceeds recent normal behavior.
Daily Chart Signals Overbought Extremes for The Generation Essentials Group Stock
The daily chart shows momentum stretched to unsustainable extremes, with RSI deep in overbought territory. Both the 20-day and 50-day EMAs sit at $0.93. The 200-day EMA is higher, at $1.29. Price had drifted down toward the $0.93 area over the shorter lookback windows. Meanwhile, the longer 200-day average still reflects levels the stock held earlier in its history.
Today’s intraday price of $1.495 has jumped back above all three averages. However, because the 200-day EMA still sits above the 20-day and 50-day EMAs, this is not a clean bullish stack. It looks more like a sharp reversal candle cutting through a mixed average structure. It is not confirmation of an already-established uptrend.
Momentum Indicators at Extremes
Momentum on the daily timeframe is stretched. RSI14 stands at 85.95, deep into overbought territory. The MACD line, at 0.03, has crossed above its signal line at -0.01. That produces a positive histogram of 0.04. The crossover is technically bullish. Still, the signal line remains below zero, meaning broader daily momentum has only just begun to turn.
At the same time, price at $1.495 is trading well above the upper Bollinger Band at $1.18. The mid-band sits at $0.91. Being this far outside the bands typically signals an extended move rather than a stable trend.
Pivot Levels Frame the Risk
The daily pivot point is $1.46, with resistance at $1.93 (R1) and support at $1.03 (S1). Price is currently hovering just above the pivot. That leaves room toward R1 if buying pressure holds. However, it also exposes the stock to a retracement toward the pivot, or lower, if momentum fades.
Hourly Chart Confirms the Bullish Trend, But Conditions Remain Stretched
The hourly timeframe confirms the bullish trend but mirrors the daily chart’s overbought warnings. Price at $1.50 sits above the 20-hour EMA at $1.08. That EMA sits above the 50-hour EMA at $0.96. The 200-hour EMA rests at $0.92. That is a fully aligned bullish stack.
RSI14 on the hour is also overbought, at 82.82, but the regime reads bullish rather than exhausted. MACD confirms the picture: the line at 0.15 sits above the signal at 0.07, with a positive histogram of 0.08. However, price is now pressing against the upper Bollinger Band on the hourly chart, at $1.52. The mid-band is at $0.99. The hourly trend is intact, but stretched, echoing the same overextension seen on the daily chart.
The hourly pivot sits at $1.53, just above the current price. Resistance stands at $1.62 (R1), with support at $1.40 (S1). The stock is essentially testing the pivot from below. That level often decides whether the next move is a continuation toward R1 or a pullback toward S1.
15-Minute Chart Shows Short-Term Momentum Pausing
The 15-minute chart is the first to show hesitation, with momentum flattening near the pivot. Price is consolidating tightly between $1.48 and $1.52, right around the 15-minute pivot of $1.50. Meanwhile, RSI14 has eased to 60.58 from the extreme readings on higher timeframes. That suggests the most aggressive buying has paused for now.
The MACD histogram has turned slightly negative, at -0.01. The line at 0.12 has dipped just below the signal at 0.13. That is a minor, short-term warning sign. Momentum on the smallest timeframe is stalling. Yet the broader daily and hourly structures remain constructive.
Overall, the three timeframes tell a layered story. The daily chart shows a powerful breakout candle, but it rides on extremely overbought RSI and a price far outside its Bollinger Bands. Those conditions typically invite a cooling-off period. The hourly chart confirms the bullish trend structurally, with EMAs properly stacked. Yet it shares the same overbought and band-stretched characteristics. The 15-minute chart, meanwhile, is the first to show hesitation. In short, the bias is bullish but exhausted. Short-term signals warn that a pause or partial retracement is a live possibility even within an intact uptrend.
Bullish Scenario for The Generation Essentials Group Stock
A bullish continuation scenario would need the stock to hold above the daily pivot at $1.46. It would also need to hold the hourly support at $1.40. A push through the hourly resistance at $1.62 would open the way toward the daily R1 at $1.93. For that scenario to have real staying power, the daily MACD signal line would eventually need to climb back above zero. That would confirm momentum has genuinely shifted, rather than just spiked for a session.
Bearish Scenario and Invalidation Levels for TGE
On the other hand, a corrective scenario would likely start with a break below the 15-minute support at $1.48. A break below the hourly pivot at $1.53 would add pressure. A deeper slide back toward the daily pivot at $1.46, and eventually toward S1 at $1.03, would suggest today’s spike was a volatility event. It would not signal the start of a sustained trend.
A break back below the daily 200-day EMA at $1.29 would be significant. A further drop toward the 20-day and 50-day EMA cluster at $0.93 would invalidate the bullish case entirely. That would put the stock back into the same lower range it occupied before today’s move.
Closing Thoughts on The Generation Essentials Group Stock
For now, positioning around The Generation Essentials Group stock has to account for extreme volatility. A clean directional read is not available. RSI is stretched across both the daily and hourly charts. Price is trading well outside its Bollinger Bands on both timeframes. Therefore, further whipsaw action looks more likely than a smooth continuation.
Traders watching TGE should treat current levels as a test. The question is whether the breakout can consolidate into a real trend. Alternatively, price may settle back toward the pivots that defined the stock before today’s surge. Given the size of today’s move, uncertainty remains the dominant feature of this chart.
FAQ
How much did The Generation Essentials Group stock rise on September 30, 2026?
TGE shares were trading at $1.495, up 80.12% from the previous close of $0.83, as of 14:17 ET on September 30, 2026. Volume reached 168,389,984 shares.
Is TGE overbought after the intraday surge?
Yes. Daily RSI14 reached 85.95, and hourly RSI14 hit 82.82. Both readings are deep in overbought territory. Price also traded well above Bollinger Bands on both timeframes, signaling extreme conditions.
What are the key support and resistance levels for TGE?
Key support sits at the daily pivot of $1.46 and S1 at $1.03. On the downside, the 200-day EMA at $1.29 and the EMA cluster at $0.93 are also critical. Resistance stands at hourly R1 of $1.62 and daily R1 of $1.93.
Could The Generation Essentials Group stock retrace after this surge?
A corrective scenario is possible given the extreme overbought readings. A break below the daily pivot at $1.46 could open the way toward S1 at $1.03. A drop below the 200-day EMA at $1.29, followed by the 20-day and 50-day EMA cluster at $0.93, would invalidate the bullish case.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

ImmunityBio stock surged 10.25% on Wednesday, trading at $9.735 as of 14:04 ET. Volume reached 1,030,971 shares. The rally pushed shares to recent intraday highs without an accompanying news catalyst. The daily chart confirms the bullish backdrop.
IBRX — daily chart with candlesticks, EMA20/EMA50 and volume.
Key takeaways
ImmunityBio stock jumped 10.25% to $9.735, reaching the highest intraday levels in recent sessions.
The daily EMA stack is fully bullish, with price above the 20-, 50-, and 200-session EMAs.
Daily RSI at 67.02 and positive MACD confirm momentum, though hourly RSI at 70.29 signals overbought conditions.
The 15-minute chart shows a potential short-term pause with a negative MACD histogram of -0.04.
Daily resistance sits at $10.24, with the $9.57–$9.74 pivot zone acting as key support.
ImmunityBio Stock Technical Setup: Daily Trend Turns Decisively Bullish
The daily chart shows a fully bullish EMA alignment with price above all three key averages and momentum indicators confirming the trend.
On the daily chart, price sits well above its 20-session EMA at $8.51. That average itself sits above the 50-session EMA at $8.15 and the 200-session EMA at $6.63. This creates a clean bullish stack: price above EMA20, above EMA50, above EMA200. Momentum backs it up. The 14-period RSI reads 67.02, elevated but not yet at extreme levels. The MACD line at 0.30 sits above its signal at 0.21, leaving a positive histogram of 0.09.
The Bollinger setup adds another layer. Price near $9.73 is already above the daily upper band at $9.34. The midline stands at $8.40. That kind of extension beyond the band usually signals strong directional pressure. However, it can also precede a pause as the band widens to catch up with price. Daily ATR stands at 0.57, a useful gauge of how wide normal swings have become.
Pivot levels frame the next test. The daily pivot point sits at $9.57, already cleared. Resistance stands at $10.24 and support at $9.06. Therefore, the path of least resistance on the daily timeframe points higher, provided buyers keep defending the pivot zone.
Multi-Timeframe View: Hourly Confirms, 15-Minute Flags a Pause
The hourly chart confirms the daily bullish structure, while the 15-minute chart signals a potential short-term pause. Traders should watch the divergence between higher and lower timeframe momentum.
Hourly Chart Aligns With Daily Bullish Setup
The hourly chart mirrors the daily bias. Price sits above the 20-, 50-, and 200-hour EMAs at $9.10, $8.80, and $8.28 respectively, keeping the stack aligned bullish. RSI on the hourly reads 70.29, however, which is firmly in overbought territory. This suggests the move is getting stretched on a short-term basis. MACD on the hour remains positive, with a histogram of 0.12. Momentum has not turned yet.
Meanwhile, the hourly pivot at $9.74 sits almost exactly at the current price. Resistance stands at $9.79 and support at $9.69. That tightness points to a market pausing to digest gains rather than one that has already exhausted them.
15-Minute Momentum Shows Signs of Stalling
On the 15-minute chart, the EMA stack is still bullish. Price holds above the 20-, 50-, and 200-period EMAs at $9.62, $9.26, and $8.76. However, the MACD histogram has slipped to -0.04, a negative reading that contrasts with the positive histograms on both higher timeframes. This is a short-term conflict worth noting. Intraday momentum appears to be stalling even as the broader daily and hourly trends stay intact. RSI on the 15-minute at 59.79 is consistent with a cooling-off phase rather than a reversal.
In short, the three timeframes are not perfectly aligned. Daily and hourly charts back the bullish case. The 15-minute chart hints at a pause that traders should watch before assuming the next leg higher is imminent.
Context From Recent News
No fresh company announcement accompanied today’s move. However, recent developments have shaped the broader bullish context surrounding ImmunityBio stock.
Last week, ImmunityBio shares climbed after a meeting between founder Dr. Patrick Soon-Shiong and Turkish President Recep Tayyip Erdogan. Shares jumped 9.94% on Tuesday to finish at $9.29, according to a Yahoo Finance report. That event helped set the stage for the broader advance. It does not explain today’s separate move, however.
Separately, a Yahoo Finance report on the GA-Courtenay Special Situations Fund highlighted what it called a $5.8 billion cancer market opportunity favoring ImmunityBio. Notably, the same report noted that the fund itself posted a 13.8% decline in July. That brought its year-to-date performance to -10.0%. It is a reminder that conviction in the name has come with volatility for at least one specialized fund.
Bullish and Bearish Scenarios for ImmunityBio Stock
A bullish scenario targets a breakout above $10.24 resistance. The bearish case centers on overbought conditions triggering a pullback toward the daily EMA20.
Bullish Case
The bullish case for ImmunityBio stock rests on the daily EMA alignment holding. Price would need to clear the $10.24 resistance implied by the daily pivot calculation. A sustained move through that level, supported by the hourly chart staying above its $9.74 pivot, would argue for continuation toward fresh highs. For that scenario to gain traction, the 15-minute MACD would need to turn positive again. That would confirm the short-term pause was just that—a pause.
Bearish Risks
The bearish risk starts with the overbought hourly RSI at 70.29. If price loses the hourly pivot at $9.74 and support at $9.69, a pullback becomes more likely. The retreat could extend toward the daily EMA20 near $8.51 or even the daily pivot at $9.57. A slip back below the previous close of $8.83 would be a more serious signal. It would undermine the idea that this advance can hold without a fresh catalyst.
Positioning and Outlook
ImmunityBio stock enters the remainder of Wednesday’s session firmly in bullish territory on the daily and hourly charts. Near-term caution is warranted, however, given the 15-minute signals.
Overall, ImmunityBio stock heads into the remainder of Wednesday’s session firmly positioned in bullish territory on the daily and hourly charts. The 15-minute picture, however, argues for some near-term caution. Daily ATR of 0.57 and hourly ATR of 0.23 both point to elevated volatility. Swings in either direction could be sharp. Positioning around the $9.57 to $9.74 pivot zone looks like the key battleground for the next move. Given the overbought readings on both the daily and hourly RSI, some consolidation would not be surprising before any fresh push higher. The uncertainty around that near-term pause is worth respecting.
FAQ
What is driving ImmunityBio stock higher today?
No specific news catalyst is attached to today’s session. The rally appears driven by positioning and momentum, supported by a bullish daily EMA stack with price above the 20-, 50-, and 200-session EMAs.
Is ImmunityBio stock overbought?
The daily RSI at 67.02 is elevated but not yet at extreme levels. However, the hourly RSI at 70.29 signals overbought conditions on a short-term basis, suggesting the intraday move may be stretched.
What are the key resistance levels for ImmunityBio stock?
The daily pivot resistance sits at $10.24. On the hourly chart, resistance stands at $9.79, just above the hourly pivot at $9.74.
What recent news has affected ImmunityBio stock?
Last week, shares rose after founder Dr. Patrick Soon-Shiong met with Turkish President Erdogan. Separately, a fund report highlighted a $5.8 billion cancer market opportunity favoring the company.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

Meta has found a way to turn one of Silicon Valley’s biggest spending sprees into one of the biggest tax breaks in corporate America, and the mechanism behind it is raising eyebrows in Washington. According to a New York Times investigation published September 30, 2026, Meta is using a decades-old federal research tax credit to save billions of dollars by labeling its sprawling AI data centers as “pilot models” and the Nvidia chips inside them as experimental materials. The classification lets a company spending hundreds of billions on compute infrastructure claim the same tax treatment normally reserved for lab experiments and prototypes.
Key takeaways
Meta saved $3.9 billion in federal research tax credits in 2025, up from $2 billion in 2024 and $700 million in 2023, according to the New York Times.
The company classifies massive AI data centers, including a planned 2 GW+ facility in Manhattan, as “pilot models” to qualify for the credit.
Meta is now the biggest beneficiary of this research tax credit among all publicly traded companies.
A 45 percent increase, bringing the company’s reserves for uncertain tax positions up to $18.74 billion, suggests that its own accountants perceive legal risk in the strategy.
Auditor Ernst & Young approved the approach and is now pitching it to other companies buying AI chips.
Senator Elizabeth Warren has sent questions to Meta, Google, Amazon and Microsoft about AI-related tax subsidies, CNBC reported on September 28, 2026.
Meta’s Tax Strategy on AI Data Centers and Chips
Meta is leaning on a federal research tax credit to offset the enormous cost of its AI buildout, and the trick lies in how the company describes its own infrastructure to the IRS. Facilities that Mark Zuckerberg publicly calls the backbone of Meta’s future are, on paper, treated as experiments still being tested.
Classification of AI Infrastructure as ‘Pilot Models’
In January 2025, Zuckerberg announced plans for a data center exceeding 2 gigawatts of power capacity, large enough to cover a significant part of Manhattan. For tax purposes, Meta classifies this and other similarly massive facilities as pilot models, the New York Times reported. That label sits uneasily next to what Zuckerberg told the public at the time: that these data centers would “drive our core products and business.” Calling a facility built to run Meta’s products an unproven pilot is, at the very least, a stretch that the company has had to defend.
Use of Nvidia Chips as Experimental Materials
Alongside the data center classification, Meta treats Nvidia chips deployed inside these clusters as experimental materials rather than standard production hardware. That framing, paired with the pilot-model label for the buildings themselves, forms the backbone of the company’s research tax credit claims. According to the Times, by June 2026 Meta had begun openly sharing details of its compute infrastructure with investors, covering partnerships with Nvidia, AMD, AWS, Arm and Broadcom as well as its own custom MTIA chips. None of that disclosure reads like a description of an experiment still in testing.
Financial Impact of the Research Tax Credit
The numbers behind Meta’s use of the credit have climbed sharply in just three years, turning a routine tax provision into a multibillion-dollar line item. Meta saved $3.9 billion in 2025 through the credit, up from $2 billion in 2024 and $700 million in 2023, the New York Times reported, citing Meta’s own disclosures. That trajectory makes Meta the single biggest beneficiary of this research tax credit among all publicly traded companies.
Meta defends the practice by pointing to roughly $200 billion spent on research and development over the past five years, arguing that scale alone justifies the credit. Why this matters: a tax break built for scrappy 1980s-era innovation is now subsidizing some of the largest capital expenditure projects in corporate history, and Meta’s growing reliance on it shows how far a single company can stretch a tool originally aimed at much smaller-scale experimentation.
Meta’s AI Infrastructure and Strategic Partnerships
Meta’s compute ambitions go far beyond a single building. In July 2025, Zuckerberg said Meta would “invest hundreds of billions of dollars into compute to build superintelligence,” anchoring that pledge with several multi-gigawatt clusters. The first, named Prometheus, is already partly online. A second, called Hyperion, is designed to scale up to 5 gigawatts over several years.
“We have the capital from our business to do this,” Zuckerberg wrote at the time. The company’s hardware partnerships with Nvidia, AMD, AWS, Arm and Broadcom, combined with its in-house MTIA chips, point to infrastructure built for long-term production use, not short-term testing. That gap between the language used with investors and the language used with tax authorities is at the center of the scrutiny Meta now faces.
Regulatory and Legal Risks Surrounding Meta’s Tax Credit Use
Meta’s own financial filings suggest the company knows this strategy could be challenged. The scale of its reserves tells its own story about how confident Meta’s accountants really are.
Accountants’ Warnings and Tax Reserves
In SEC filings, Meta warns investors that the tax savings from this strategy could be challenged by regulators. Uncertain tax position reserves climbed by 45 percent to reach $18.74 billion, a figure reflecting genuine internal concern about how well the company’s claims will hold up. Even if the IRS eventually claws back some of that money, Meta likely still comes out ahead, since the capital was already put to work funding data center construction and, in the process, supporting its stock price.
Role of Ernst & Young and Potential Conflict of Interest
Meta’s auditor, Ernst & Young, approved the tax strategy and reportedly helped design it in the first place. According to the New York Times, EY is now marketing this same strategy to other companies looking to offset their own AI chip purchases. That dual role, as both Meta’s auditor and the architect of a tax scheme it now sells elsewhere, adds another layer of scrutiny to a story already drawing attention from lawmakers. Separately, Senator Elizabeth Warren has sent questions to Meta, Google, Amazon and Microsoft about AI-related tax subsidies, CNBC reported on September 28, 2026, signaling that Capitol Hill is watching how the biggest tech companies are using public tax tools to fund private AI buildouts.
Origin and Intent of the Federal Research Tax Credit
The credit Meta is leaning on traces back to a law passed in 1981, decades before anyone imagined gigawatt-scale AI data centers. James Shannon, the congressman who introduced the legislation, told the New York Times it was meant to support “people power, knowledge, information.” Looking at how Meta now applies it, Shannon said the company’s use has “gone way, way beyond what anybody could have imagined.”
That gap between original intent and current application is the core tension in this story. A credit designed decades ago to reward small-scale innovation is now underwriting some of the largest infrastructure projects ever built by a private company, and Meta’s growing tax savings are a direct measure of how wide that gap has become.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.